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Microparticle array technology has developed rapidly in recent years and has wide 
applications in biochemical research field such as genomics, genetic analysis, 
biomarker detection and cancer diagnostics. As compared to solid substrates for planar 
microarrays, three dimensional microparticles allow more bioprobes to be immobilized 
per unit of area and faster binding kinetics of the biomolecules to the bioprobe. Thus, 
microparticle arrays enable faster and more sensitive biochemical assays as compared 
to conventional planar microarrays. Currently, an important method for the arraying of 
microparticles is through the physical confinement in microfabricated microstructures. 
However, most of state-of-the-art microstructures for micropaticle array assembly are 
made with either expensive glass/silicon based materials or polymeric materials 
replicating against micromolds which are fabricated in a multi-step process in specific 
cleanroom facilities. This limits the possible customization of microparticle arrays in 
common biolabs for different bioanalysis applications. In this PhD work, novel 
polyacrylamide gel based microstructures are developed for the effective assembly of 
microparticle arrays. These microstructures are fabricated with low material cost and 
minimal equipment, less process steps and shorter process time, and with no need for a 
cleanroom and micromolds. The versatility of these microstructures is demonstrated by 
the integration of microparticle arrays on three types of gel microstructure chips for 
various multiplexed biochemical assays. 
The first type of gel microstructure chip consists of gel pad array units which allow 40 
serum samples to be simultaneously analysed with volume of each sample of merely 1 
µl. As an example, quantitative microbead-based immunoassays for two tumor marker 
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proteins, hCG and PSA, are demonstrated with limits of detection lower than their cut-
off concentration for cancer diagnosis. Moreover, a multiplexed immunoassay for hCG 
and PSA is also achieved by encoding batchwise deposited microbeads with their 
spatial addresses on the array. In addition, the reusability of the chip, which is rarely 
reported in any other microarray platform, is also demonstrated. 
The second type of gel microstructure chips is designed to be integrated into a 
microfluidic system. Three different gel microstructures, gel pad arrays, gel well arrays 
and mixed microstructure arrays, have been fabricated for the assembly different types 
of microparticles. On-chip microfluidic single-plexed and multiplexed immunoassays 
for hCG and PSA in serum are demonstrated with microbeads assembled on gel pad 
arrays. Meanwhile, on-chip quantitative enzymatic glucose assays are also performed 
with microparticles assembled on gel wells arrays. Furthermore, the simultaneous 
immunoassays and enzymatic glucose assay are also achieved on chip, which is not 
reported before in any other microparticle array systems. 
The third type of gel microstructure chip is designed to be integrated into a novel PEG-
based capillary system. The capillary system consists of PEG micropillars fabricated 
by a photopolymerization reaction. The filling time and average flow rate of liquid on 
the capillary system is simply altered by modification with different concentrations of 
Tween® 20. The chip is tested by single-plexed and multiplexed microbead-based 
immunoassay for PSA and hCG with total assay time of 10 min and without any 
repeated washing steps. This is the first bioanalytical microbead array to be integrated 
into an autonomous capillary system for multiplexing biochemical assays.
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Chapter 1 - Introduction 
 
1.1 Background 
Microarray technology has developed rapidly in the last two decades and it has 
become the leading technologies for multiplexing analysis of biomolecules. In a 
conventional microarray, different bioprobes are immobilized onto a planar substrate 
in a spatially addressable manner with each bioprobe targeting one specific 
biomolecule [1]. By incorporating thousands of micrometer sized bioprobe spots onto 
the substrate chip, a microarray enables the simultaneous multiplexed biochemical 
assays in a miniaturized format. Nevertheless, on a planar microarray, the binding 
kinetics of target biomolecules to the surface bioprobes are greatly limited by the two 
dimensional diffusion, which leads to a long assay time. For example, the 
hybridization of target DNA with the oligonucleotide probe on a planar DNA 
microarray could take more than 18 hrs [2].  
Microparticles have been used in biochemical assays for over fifty years [3]. Owing to 
their three dimensional nature, microparticles allow more bioprobes to be immobilized 
per unit of area, while they also enable faster binding kinetics of biomolecules to 
bioprobes as compared to the bindispatiallinetics on a planar microarray [4]. Thus, 
microparticles microarray enables the faster and more sensitive biomolecule analysis 
than the conventional planar microarray. For example, Ng et al. [5] developed an 
oligonucleotide microbead array which was able to detect target DNA in merely 10 
min. Due to these advantages, microparticle arrays have found wide applications in 
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biochemical research fields such as genomics [6, 7], genetic analysis [8, 9], biomarker 
detection [10-12] and cancer diagnostics [13, 14].  
The majority of the state-of-the-art microparticle arrays utilize the orderly assembled 
biofunctionalized microparticles on certain solid substrates [15-17]. Currently, most of 
the microparticle arrays are assembled on the solid substrate either with the assistance 
of external forces, such as magnetic forces [18-20], electric forces [21, 22] and 
electrostatic forces [23-25], or with the confinement in certain physical 
microstrucutures [9, 12, 16, 17, 26]. The external forces assistant assembly, as it 
requires pre-patterned microcomponents on the substrate (micromagnets, 
microelectrodes and patterns of charged molecules), usually involves fabrication 
process in cleanroom facilities with expensive equipment which are not accessible for 
most biolabs. Furthermore, external forces assistant assembly is incapable to pattern 
non-magnetic and non-charged microparticles which could also limit its application. In 
contrast, the physical confinement method is applicable to most microparticles 
regardless of their chemical or physical properties. Silicon/glass microstructures were 
the first to be utilized for physical confinement of microparticles [15, 26, 27]. However, 
the expensive substrate material as well as the complicated microfabrication process 
could be a limitation. Recently, inexpensive polymeric materials, such as PDMS, 
cyclic olefin copolymer (COC) and optical epoxy resin, have been more frequently 
employed for the fabrication of microstructures for microparticle assembly [17, 28-30]. 
The fabrication of these polymer microstructures is based on molding [17, 30]  or 
embossing [28] against certain micromolds and is less complicated than the fabrication 
of silicon/glass microstructures as these molds are usually reusable. Despite that, if 
polymeric microstructures can be fabricated even without a micromold which is 
usually microfabricated on silicon or metal substrate in a cleanroom, the entire 
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fabrication process for microparticle arrays could be further simplified and the 
microparticle array could be potentially more customizable to most researchers.  
Another important issue for microparticle arrays, when being applied for bioanalysis, 
is the delivery of different bio-reagents to the array during the biochemical assays. 
Microfluidics, with its minute volume, fast mass transfer rate and automated flow 
control, is a good candidate for reagent delivery [31].  Thus, microparticle arrays have 
been integrated into microfluidics for rapid, sensitive and multiplexed biochemical 
assays [32-34]. For most microfluidic microparticle arrays, the delivery of the reagent 
requires external pumping elements such as syringe pumps or peristaltic pumps. 
Although these pumps can automatically and precisely control the flow rate, they are 
usually bulky in size and are connected with external power sources.  This could limit 
the application of microparticle arrays in on-site point-of-care tests. The idea of 
passive pumping, which integrates the self-pumping element inside the microfluidic 
system, could be a solution to this limitation. Although various passive pumping 
methods have been developed [35-37], none of them has been employed for 
integration with microparticle arrays for bioanalysis. Therefore, it will be promising to 
develop microfluidic devices with integration of microparticle arrays as well as passive 
pumping elements for multiplexed point-of-care test.  
On the other hand, while existing microparticle arrays focus mainly on the multiplexed 
analysis of different biomolecules of one category (e.g. different proteins [10], DNAs 
[38] or small metabolites [39]) by one type of biochemical assays (e.g. immunoassay, 
DNA hybridization assay or enzymatic assay), few has been reported for the 
multiplexed detection of different categories of biomolecules. In fact, the multiplexed 
detection of different categories of biomolecules is desired for specific biomedical 
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applications. For example, the diagnosis of pancreatic insulinoma is based on the 
measurement of serum glucose level as well as the serum insulin level with two assays, 
the enzymatic glucose assay as well as the immunoassay for insulin [40]. Another 
example is the diagnosis of colorectal cancer by measuring the serum level of 
carcinoembryonic antigen (CEA) and the serum free DNA which also require two 
assays, an  immunoassay for CEA and a PCR based assay for free DNA [41]. In these 
two cases, if an array can be fabricated incorporating microparticles biofunctionalized 
with bioprobes for specific protein, DNA and glucose, different categories of 
biomolecules could be measured with merely one assay and the time required for 
diagnostics will be greatly shortened. Thus, there is a need to fabricate arrays of 
microparticles with different bioprobes to simultaneously perform different 
biochemical assays for the detection of different categories of biomolecules.  
To summarize, most of the current methods for the fabrication of polymeric 
microstructures for physical confinement of microparticles require micromolds which 
are fabricated in specific cleanroom facilities with expensive equipment. The 
fabrication cost and time could be greatly reduced if microparticles could be assembled 
on polymeric microstructures which are fabricated with mold-free methods and with 
minimal equipment required. Furthermore, currently, no bioanalytical microparticle 
array has been integrated into an external-pump-free microfluidic system to be 
optimized for point-of-care tests and no efforts has been made to enable the 
multiplexed detection of different categories of biomolecules with a single 
microparticle array for potential biochemical applications.  
Therefore, there is a need to develop mold-free fabricated polymeric microstructures 
for the assembly of microparticle arrays which can subsequently (1) be used for 
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multiplexed biochemical assay for biomolecules either from the same category or from 
different categories (2) be integrated into a passive pumping element embedded 
microfluidic system for multiplexed point-of-care tests.  
 
1.2 Objectives and specific aims  
The main objective of this work is to develop a microparticle array platform based on 
the mold-free fabricated gel microstructure chips, to subsequently apply this 
microparticle array for the multiplexed biochemical assays for different categories of 
biomolecules and to integrate the microparticle array into an external-pump-free 
microfluidic system. 
To accomplish the main objective, there are four specific aims to be completed: 
Specific Aim 1: To develop mold-free fabricated polyacrylamide gel microstructures 
with low background fluorescence for the assembly of microparticle arrays.  
Specific Aim 2: To integrate the microparticle arrays assembled on gel based 
microstructures into a microchip for quantitative, multiplexed and high-throughput 
immunoassays. 
Specific Aim 3: To integrate the microparticle arrays assembled on gel based 
microstructures into a microfluidic system for the simultaneous multiplexed 
immunoassay and enzymatic assay for the detection of proteins and glucose. 
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Specific Aim 4: To integrate the microparticle arrays assembled on gel based 
microstructures into an autonomous capillary microfluidic system for multiplexed 
immunoassays.  
 
1.3 The scope 
This thesis work includes the development of polyacrylamide gel microstructures for 
the assembly of biofunctionalized micropaticle arrays and the integration of these 
microparticle arrays into chip-based platforms for the applications in miniaturized 
multiplexed biochemical assays, especially in immunoassay, enzymatic assay and 
hybridization assay. With very low material cost and minimal equipment required, 
with short process time and no cleanroom work involved, the fabrication of gel 
microstructures can be easily adapted for most biolabs. Therefore, it could be useful 
for researchers to rapidly fabricate and assemble microparticle arrays for various 
bioanalysis applications.  
In the first part of the work, a gel pad array chip has been developed to hold multiple 
microbead arrays for high throughput immunoassays for serum samples. The 
performance of the chip is tested with both single-plexed and multiplexed microbead 
based fluorescence immunoassays for tumor marker proteins. Moreover, the stability 
of microbeads on the gel pad array during the assay is also investigated. Another 
special feature, the reusability of the chip, which is rarely reported in other 
microparticle array platforms, is also validated. Lastly, the one-assay integration of 
DNA hybridization assay and immunoassay is also demonstrated. 
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In the second part of the work, microparticle array assembled on gel microstructure 
chip is integrated into microfluidics for microfluidic quantitative immunoassays and 
enzymatic assay. The simultaneous detection of two tumor markers and glucose is 
achieved by the first time in the literature, the integration of immunoassays and 
enzymatic assay in a microparticle microarray platform.  
In the third part of the work, a chip with novel PEG-based capillary microfluidic 
system is fabricated in a simple fabrication process with minimal equipment required. 
A simple surfactant surface modification method is employed to alternating the filling 
time and average flow rate of liquid in the capillary system.  By integrating gel pad 
arrays into this capillary system chip, we demonstrate the first multiplexed 
immunoassay with a microbead array in a passive pumping element embedded 
microfluidic system. With only 10 min assay time and no external pump or energy 
source required, the integrated chip could be potentially contributed to the multiplexed 
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Chapter 2 - Literature Review 
 
2.1 Introduction 
Microparticles have been used in biochemical assays for over fifty years [3]. The 
advantages utilizing the microparticles rather than conventional two dimensional solid 
substrate for biochemical assays lie in their high surface to volume ratio which allows 
more bioprobes to be immobilized and the three dimensional diffusion which results in 
faster reaction/binding kinetics between the target biomolecules and bioprobes [4, 42, 
43]. The assembly of microparticles into a microarray format not only embraces all the 
above advantages but also enables multiple biomolecules to be detected and analyzed 
[44]. Therefore, the microparticle array has been widely used in various kinds of 
biochemical assays such as in immunoassays [10, 29, 45-47], DNA hybridization 
assays [5, 6, 9, 38, 48] and enzymatic assays [49]. 
The two major formats of microparticle arrays are suspension microparticle microarray 
and on-substrate microparticle microarray. Suspension microparticle array technique, 
which was developed by Luminex Corporation, employs color-encoded microparticles 
suspended in liquid for the biochemical assays [50]. The microparticles encoded with 
different ratio of two dyes are attached with different bioprobes and are mixed together 
in solution, thus forming a suspension microarray [51]. Besides the suspension 
microparticle arrays, the majority of the other microparticle arrays are assembled on 
certain substrates. In this chapter, we emphasize mainly on the current methods for the 
fabrication of on-substrate microparticle arrays and their applications in bioanalysis. 
The following review will cover (1) the state-of-the-art methods for the assembly of 
micropartcle arrays; (2) microparticle encoding methods for multiplexed biochemical 
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assays and (3) the application of microparticle arrays in biochemical assays. In 
addition, recent progress in the development of capillary pump systems for 
biochemical assays will also be reviewed. 
 
2.2 Methods for the assembly of microparticle array 
One challenge for the fabrication of microparticle arrays is the manipulation and 
assembly of minute and highly mobile microparticles into an ordered pattern/array. In 
recent years, various methods have been developed for the assembly of microparticles 
with the most notable ones including magnetic force assisted self-assembly, electric 
field assisted self-assembly, electrostatic force assisted self-assembly, optical 
manipulation and physical confinement.  
 
2.2.1 Magnetic force assisted self-assembly 
The utilization of paramagnetic microparticles in the biochemical assays can be 
retrospected to over 30 years ago [52]. To assemble a paramagnetic microparticle array, 
magnetic force should be applied to manipulate and pattern the microparticles onto the 
substrate. The generation of the magnetic force could be from external macroscopic 
magnets, integrated microscopic magnets or integrated micro-electromagnets [53]. For 
example, Fan et al. [54] demonstrated the patterning of magnetic microparticles in 
eight separate microchannels by using an external bulk magnet. The patterned 
biofunctionalized microparticles were used as a bioarray for the simultaneous detection 
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of multiple target oligonucleotides. Alternatively, Smistrup et al. [18] integrated 
magnetized permalloy into the microfluidic chip for the attraction of magnetic 
microparticles. With multiple permalloy micro-magnets, microparticles arrays can be 
fabricated on the side wall of the microchannel and be used for the multiplexed 
biochemical assay. Another approach, pioneered by Choi et al. [55], was the 
integration of electromagnets for the capture and pattern of magnetic microparticles. 
The advantage using electromagnets instead of permanent magnets is the flexibility to 
control the magnetic force by changing the current in the conductor coil thus allowing 
the capture and releasing of the microparticles. While all the above works only 
demonstrated the assembly of clusters of microparticles, Xu et al. [19] recently 
fabricated permalloy disk and line arrays which allows the assembly of single 
paramagnetic microparticle arrays. The limitations of the magnetic force assisted 
microparticle array assembly are (1) Single microparticle array cannot be fabricated by 
using bulky external macroscopic magnets. (2) Complicated fabrication processes are 
usually required for the integration of microscopic magnets and micro-electromagnets.  
 
2.2.2 Electric field assisted self-assembly 
Charged microparticles can be captured and manipulated under certain electric field 
due to the electrostatic attraction between the electrode and the microparticles [56, 57]. 
By integrating microfabricated microelectrode arrays onto the substrate, microparticles 
can be assembled in an ordered array both in dry conditions [22, 58] and in solution 
phase [59]. The advantage to array charged microparticles in dry conditions lies in the 
high stability of immobilized microparticles after the retrieval of the electric field as 
these microparticles will not move randomly through Brownian motion [22]. In 
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contrast, the retrieval of electric field in solution phase usually leads to the random 
movement of microparticles [56]. Barbee et al. [21] solved this problem by patterning 
protein-coated microbeads directly on gold microelectrodes which have high non-
specific affinity to the proteins. The resulting stably arrayed microparticles in solution 
phase allowed the immediate integration with biochemical assays. While the electric 
field assisted assembly possesses the superiority of much shorter assembly time (tens 
of seconds) over other microparticle assembly methods, it also has obvious limitations 
such as the complicated fabrication process for microelectrode arrays and the restricted 
application for only charged microparticles. 
 
2.2.3 Electrostatic force assisted self-assembly 
Another method for the assembly of charged microparticle arrays is the electrostatic 
force assisted assembly. In a pioneer research, Aizenberg et al. [23] employed 
micropatterned anionic or cationic self-assembly monolayers (SAMs) for the assembly 
of polystyrene microparticles arrays. Sivagnanam et al. [24] extended this approach by 
assembly of protein-coated microparticles on patterned SAMs with the opposite charge. 
Arrays of single or multiple microparticles were fabricated by controlling the size of 
the SAM patterns and the arrayed microparticles were directly used for the 
biochemical assays [33]. Besides the charged SAMs, polyelectrolytes were also 
frequently employed for the patterning of charged regions for microparticle assembly 
[25, 60, 61]. However, the patterning of both SAMs and polyelectrolytes requires 
complicated photolithography procedures in cleanroom such as the fabrication of 
masters for the stamp of microcontact printing (µCP) [23] and the fabrication of 
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templates for the patterning of silanes [62]. This limits the utilization of electrostatic 
assisted self-assembly methods in common biochemistry labs.  
 
2.2.4 Optical manipulation 
The manipulation of microparticles with optical force was first demonstrated by 
Ashkin in 1971 [63]. In this study, single microparticle was selectively accelerated and 
captured by applying a radiation pressure using laser beam. This was later developed 
into the “optical tweezer” technique for the manipulation of particles [64] as well as 
cells [65] and atoms [66]. Although the early generation of optical tweezers achieved 
accurate manipulations of microparticles, they were limited to the capture of one 
microparticle at one time and were not suitable for the assembly of an array of 
microparticles. To manipulate multiple microparticles at one time, Tam et al. [67] 
developed an optical tweezer array using fiber optic bundles to split laser beam for the 
simultaneous manipulation of more than one hundred microparticles. Another 
approach reported by Merenda et al. [68] employed micromirror array to split the laser 
and thus allowing multiple microparticles to be arrayed. This approach was further 
advanced by using a programmable digital micromirror device (DMD) which is able to 
pattern hundreds to thousands of spatially addressable microparticles [69]. The 
advantage of optical manipulation method lies in its capability to directly pattern 
microparticles without the need for the fabrication of any physical templates or 
chemical micropatterns. However, the inability for the simultaneous assembly of large 
number of microparticles as compared to other methods (hundreds versus millions) 
and the requirement of expensive laser light source could hinder the application of 
optical manipulation methods in the fabrication of microparticle arrays. 
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2.2.5 Physical confinement 
Physical confinement method, which employs certain physical microstructures to 
constrain the microparticles, is a more straightforward approach for the fabrication of 
microparticle arrays. Compared to the external force (e.g. magnetic force and electric 
field) assisted assembly of microparticle array, the physical confinement method only 
relies on the geometry and the size of the microstructure for the patterning of either 
single or multiple microparticle arrays [16]. Thus, it is not restricted for the assembly 
of specifically modified microparticles (e.g. magnetic or charged micropaticles) but for 
microparticles made with different materials and of various geometries. Silicon/glass 
and polymer are the two categories of most frequently used materials for the 
fabrication of microstrcutures for microparticle array assembly.  
 
2.2.5.1 Silicon and glass microstructures 
Silicon and glass based materials are the basis for the semiconductor industry and 
numerous standardized fabrication protocols are available for the fabrication of 
microstructures on these substrates. Thus, it is not surprising that the fabrication of 
microparticle array was initially achieved on silicon and glass based microstructures. 
Professor David Walt’s research group reported first high density microparticle array 
assembled on end-etched glass optic fiber bundles in 1998 [70] (Figure 2.1a). The 
distal faces of every optical fiber core can be etched out by hydrofluoric acid [71] or 
hydrochloric acid [10] thus forming microwells which are separated from each other 
by the inert cladding layers. A high density array of microparticles was then 
successfully fabricated on these microwells [15]. The assembled microparticles arrays  




Figure 2.1 Microparticle arrays assembled on glass/silicon based microstructures. (a) 
Microbead array assembled in microwells on an end-etched optical fiber (From [70]). 
(b) Microbead array assembled on microwells etched on a silicon wafer (From [72]). 
 
has been widely used in various applications such as immunosensing [73], DNA 
hybridization assays [74], aptamer based assay [75] and artificial olfaction [76]. This 
technique was also commercialized by Illumina, Inc [77]. Besides the optical fiber 
array technique, Illumina also commercialized the technique to assemble microparticle 
on microwells etched on a silicon wafer which was named as BeadArrayTM platform 
[7]. Professor John McDevitt’s research group also employed etched silicon 
microwells for the assembly of biofunctionalized microbeads [26, 72] (Figure 2.1b). 
Different from optical fiber array platform and BeadArrayTM platform, microparticles 
were immobilized in through-etched microwells which allowed the reagents to pass 
though freely. This enabled the direct integration of the microparticle array into 
microfluidic systems for biochemical assays [9, 78, 79]. However, there are two 
drawbacks for this system: (1) only relatively big microparticles (>100 µm [9, 72, 78, 
80]) can be assembled due to the size of microcavities (upper diameter >200 µm) 
which limited the maximum number of microparticles per unit of area; (2) 
microparticles were transferred into each microwell manually with a micro-
manipulator in a one particle one time manner [26, 81] which is not applicable for the 
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fabrication of high-density microparticle array for high multiplexing biochemical 
assays. For the above microparticle arrays assembled on silicon and glass based 
microstructures, the limitation lies in their requirement for expensive substrate 
materials (silicon wafers, glass wafers or glass optic fibers) as well as multi-step 
fabrication process in specialized cleanroom facilities with well-trained technicians. 
 
2.2.5.2 Polymer microstructures 
Polymer is another widely used substrate material for the fabrication of 
microstructures for microparticle assembly. Compared to the silicon and glass based 
materials, polymeric materials are less costly and more flexible for casting, molding 
and patterning. Most of the current polymer microstructures for microparticle 
assembly are fabricated by molding against certain templates. Zhou et al. [12] 
fabricated PDMS based microchambers integrated with microfluidic channels by soft-
lithographical replica molding method against silicon masters for the assembly of tens 
of antibody-coated microbeads for microfluidic immunosensing [82], DNA detection 
[83] and RNA detection [34]. Lim et al. [17] advanced the technique by the assembly 
of more than ten thousands of microbeads on novel dome-shaped PDMS 
microstructures which is molded against a specially made master (Figure 2.2a). 
PDMS itself was also used as a template for the molding of epoxy resin based 
microcavities for microparticle assembly [29]. While the molding of PDMS based 
microstructures still requires microfabricated silicon or glass masters, microstructures 
can also be fabricated with microfabrication-free methods such as breath figure method 
[84]. Lu [85] et al. used breath figure method to fabricate micropores on silica-
polystyrene hybrid polymer films with condensed water droplets as template. Different 




Figure 2.2 Microparticle array assembled on polymer based microstructures. (a) 
Microbead array assembled on a PDMS based microstructure made by replica molding 
(From [17]). (b) Microparticle array assembled on polystyrene/silica porous film made 
by breath figure method (From [85]). 
 
sized micropores can be generated by controlling the ratio between silica and 
polystyrene in polymer solution, thus fitting for microparticles with different sizes 
(Figure 2.2b).  
As an alternative method to mold/template assistant molding, Jason et al. [86] reported 
the fabrication of a microwell array by direct hot-embossing of a silicon master against 
cyclic olefin copolymer (COC) substrate. The embossing process only took seconds 
time and the resulting microwells provided good immobilization stability of antibody-
coated polymeric microbeads [28]. Ng et al. [5] developed photo-patterned 
polyacrylamide gel pad arrays which were subsequently employed for the assembly of 
oligonucleotide coated microbeads with 100% immobilization stability. Different from 
the conventional photolithography methods for photoresist patterning, the fabrication 
of these gel based microstructures is a one-step process and requires no cleanroom 
facilities. Both of the above two approaches enable rapid fabrication of polymeric 
microstructures without the need for expensive sophisticated equipment and could thus 
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provide simple and effective solutions for the fabrication of robust biofunctionalized 
microparticle arrays for common biochemistry labs. 
 
2.2.6 Miscellaneous methods 
Methods for the fabrication of microparticles arrays, which cannot be categorized into 
the above five methods, were also developed by multiple research groups. Lee et al. 
[87] fabricated a microparticle array on a photo-curable adhesive layer which was 
microcontact printed with removable polymer template (RLP) in advance. After 
triggering the adhesion between the microparticles and the adhesive layer by UV 
exposure, RLP was removed by a water/ethanol (80/20) solution, leaving an array of 
microparticles which only sit on the non-patterned region on the adhesive layer. Yan et 
al. [88] used µCP method to directly printing arrays of microparticles onto the 
poly(vinyl alcohol) film. By solvent swelling or mechanical stretching of the PDMS 
µCP stamps, microparticle arrays with different patterns and intra-particle distances 
can be fabricated [89, 90]. Lilliehorn et al. [91] reported the acoustic manipulation of 
single microparticle for array assembly using ultrasonic transducers. The resulting 
biofunctionalized microparticle array was proved to be robust in microfluidic binding 
assays [92]. Another interesting method was introduced recently by Palla-Papavlu et al. 
[93] who employed a physical phenomenon called “laser induced forward transfer” for 
the selective transfer of microparticle onto the target substrate. The microparticles 
were transferred from the donor substrate to the target substrate by the propelling 
energy generated during the laser induced decomposition of sacrificial layer on the 
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donor substrate. Arrays of clusters of microparticles can thus be assembled by control 
the laser radiation position on the donor substrate. 
 
A summary of the current method for the assembly of microparticle arrays is 
demonstrated in Table 2.1. 
 
2.3 Microparticle encoding methods 
Microparticle encoding methods were initially developed for applications in 
combinatorial chemistry for the screening of particular synthesized chemicals from a 
microparticle based combinatorial library [94]. As applied in bioanalytical 
microparticle arrays, proper encoding methods allow the distinguishment of 
microparticles functionalized with different bioprobes which enable the correlation of 
the output signals with the correspondence biochemical interactions/reactions [95]. 
Several encoding methods are currently adopted for microparticle arrays used for 
multiplexed biochemical assays, with three of them most frequently used: color 
encoding method, barcode encoding method and spatial encoding method.  
 
2.3.1 Color encoding 
A most prevailing microparticle encoding method is the color encoding method which 
employed spectrally distinct microparticles prepared by embedding chromophores, 
fluorophores or semiconductive nanocrystals onto the particle surface or into the 
particle matrix [96, 97]. A most straightforward way for color encoding is to dope  
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different microparticles with different fluorescent dyes. Egner et al. [98] demonstrated 
the labelling of different microparticles with six spectrally distinct fluorescence dyes 
which can be easily distinguished by a fluorescence microscope. The problem with the 
“one dye one bead” approach is the limited number of codes which can be generated as 
restricted by the availability of different spectrally distinct dyes. Luminex Corporation 
reported an improved approach by doping microparticles with different ratios of two 
organic dyes to generate 100 different types of microparticles which can be later 
 
Figure 2.3 Microparticles encoded by color. (a) Microparticles encoded with quantum 
dots (From [99]). (b) Microparticles encoded with silica colloidal crystal (From [100]). 
 
decoded by a customized flow cytometer [38]. In this case, the microparticles are not 
only discriminated by their colors but also by the emission intensity in certain 
wavelength. Furthermore, with the same approach, the number of different types of 
microparticles can be potentially increased if three or more dyes are doped [47]. 
However, the organic dyes usually suffer from photobleaching problem and the 
emission of organic dyes require multi-wavelength excitation light source which could 
add complexity for the optical detection system.  
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As an alternative to organic dyes, inorganic semiconductor nanocrystals, named 
“quantum dots”, were also employed for the encoding of micorparticles. Compared to 
organic dyes, quantum dots embrace several advantages such as the non-bleaching 
nature, the single-wavelength excitation for multi-wavelength emission, tunable 
emission wavelength and narrower emission peak [101]. Han et al. [99] doped 
microparticles with different intensity and color of quantum dots for color encoding 
(Figure 2.3a). Theoretically, six different colored quantum dots at 10 different 
intensities levels could create one million types of encoded microparticles. A slight 
concern for quantum dots is the high cytotoxicity of cadmium and selenium which 
may require extra safety measures. Besides quantum dots, photonic crystals were also 
used for the spectral encoding of microparticles [102]. Cunin et al. [103] reported the 
first research using photonic crystal microparticles as the microcarrier for biochemical 
assays. By adjusting the pore size of silicon photonic crystals during the 
microfabrication process, microparticles with different visible spectra can be obtained. 
Hereafter, the process for making these encoding photonic crystal microparticles was 
simplified by Zhao et al. by assembly microbeads with silica nanoparticles [100] 
(Figure 2.3b). The robustness of this approach is the direct integration of the spectral 
code with the microparticles during the fabrication process, thus eliminating the need 
for any doping or embedding of dyes or nanocrystals. The advantages using these 
photonic crystals for color encoding lie in their extremely narrow emission peak (ca. 
11 nm full-width at half-maximum, FWHM [103]) as well as their colormetric 
visibility which can be distinguished without fluorescence excitation. A more 
advanced method was developed by Tang et al. [104] who employed both photonic 
crystal particles and quantum dots for color encoding. The number of codes that can be 
generated was multiplied by encoding the microparticles with the binary combination 
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of the fluorescence spectra of quantum dots and the reflective spectra of photonic 
crystals. Nevertheless, the major limitation of the current color encoding methods is 
the lack of readout equipment powerful enough to resolve more than 100 different 
combinations of colors and intensities which is the maximum number reported until 
today by Lunimex Corporation [38].  
 
2.3.2 Barcode encoding 
Another widely used approach for the encoding of microparticles for multiplexed 
biochemical assays is the barcode encoding approach [105]. Nicewarner-Peña et al. 
[106] reported the fabrication of microrods with metal stripes. As each metal material 
has its distinct reflective spectrum, the combination of these metal stripes served as 
one dimensional barcode for the encoding of microrods. Theoretically, unlimited 
numbers of barcoded microrods can be fabricated by alternating the number of metals 
employed and the order and the width of each metal strip. With an alternative approach, 
Dejneka et al. [107] developed glass microparticles striped with different rare earth for 
barcoding. The different fluorescent patterns of the rare earth on each microparticle 
can be identified by using a simple fluorescence microscope and both one dimensional 
and two dimensional barcodes can be fabricated [108]. However, the general 
applications of the above two methods for micropartiles barcode encoding are limited 
by the expensive materials (gold, silver, platinum and rare earth) used, the very 
specialized and complicated multistep fabrication process involved and the powerful 
readout system required for resolving the spectral pattern [107, 109]. SmartBead 
Technologies fabricated aluminium microrods with different patterns of one-
dimensional etched holes for barcode encoding [110]. The identity of each microrod 
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was recognized by the length and position of etched holes, which requires no spectral 
resolving devices for decoding. However, the aluminium material may not be ideal for 
the attachment of bioprobes. Biocatis [111] recently developed silicon based 
microparticles with two dimensional etched holes as barcodes. With the well-known 
surface chemistry of silicon, it is more feasible to attach bioprobes (e.g. antibodies) to 
the microparticle surface for multiplexed biochemical assays. Besides the metal and 
silicon, polymeric SU-8 photoresist was also employed for the fabrication of barcoded 
microparticles [112, 113]. With proper surface functionalization [114], SU-8 could be 
an inexpensive material to generate biofunctionalized barcoded micropaticles for 
biochemical assays [113]. 
Another innovative method to generate barcode on microparticles is through the spatial 
selective photobleachng of different regions on the surface of fluorescent 
microparticles to directly “write” graphic barcodes [115]. Infinite number of codes can 
be generated as virtually all types of barcodes can be written on the microparticle 
surface with this method. However, the requirement of expensive laser scanning 
confocal microscope as well as the time-consuming “one-paticle-one-time” fabrication 
process could limit the general application of this method.   
While all the approaches mentioned above are either involved with complicated 
microfabrication in cleanroom or limited by the time-consuming fabrication process, 
Professor Doyle’s research group developed a one-step approach for the rapid 
fabrication of two dimensional barcoded microparticles, which is name as 
“Continuous-flow Lithography” [116]. The dot-codes as well as the rest part of the 
microparticles were synthesized in milliseconds time by illuminating microfluidic flow 
of poly(ethylene glycol) diacrylate prepolymer solution with the UV source through a 
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soft-mask [117]. In theory, this system has the power to fabricate more than one 
million different types of barcoded microparticles and these encoded microparticles 
can be aligned in a microchannel and subsequently be screened and recognized in high 
throughput by a high-speed imaging system [118]. Moreover, the capability of 
simultaneous incorporation of barcodes and bioprobes in synthesis process is not 
applicable for any other barcoded microparticle fabrication methods. However, the 
relatively large particle size (~100 µm) and the small pore size of the PEG gel [119, 
120] could slow down the diffusion of big-sized biomolecules (e.g. DNAs and proteins) 
towards bioprobes, thus affecting the reaction kinetics and extending the assay time (> 
1.5 hrs [121]).  
 
2.3.3 Spatial encoding 
Spatial encoding method is widely used in conventional planar microarrays where 
different bioprobes are discriminated by their addressable position on the substrate [2, 
122]. The prerequisite to encode microparticles with spatial positions is the great 
stability of immobilized microparticles which will not move during the encoding as 
well as the biochemical assay process. Goodey et al. [26] demonstrated the 
arrangement of five types of microparticles which were attached with different 
complexones (metal chelating reagents) for the detection of three types of metal ions. 
Microparticles were transferred into micro-cavities etched on a silicon chip and the 
identity of each microparticle was encoded by their spatial position on the micro-cavity 
array. This approach was further employed for the encoding of microparticles 
functionalized with enzymes [81], oligonucleotides [9], aptamers [79] or antibodies 
[72] for multiplexed biochemical assays. The similar spatial encoding approach was 
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also employed by Zhou et al. [12] to address antibody microparticles in a one-
dimensional array for multiplexed immunoassay. However, in these early works, the 
manual “one-by-one” assembly of individual microparticle made the encoding process 
tedious. As a result, the number of microparticles can be assembled was limited and 
the multiplexing power as well as the redundancy of the data points was also 
compromised. As an improvement, Ng et al. [5] demonstrated the spatial encoding of 
 
Figure 2.4 Spatial encoding of microbeads by sequential deposition (From [5]).  
 
microparticles by analyzing images captured after random deposition of each batch of 
microparticles on a gel pad array (Figure 2.). The unique sticky property of the gel 
enabled the stable immobilization of microparticles which remained in their spatial 
position during the encoding/decoding process. The different types of microparticles 
can thus be assembled on gel pad array by simple pipetting and the redundancy of each 
batch of microparticles was greatly increased. By adjusting the density of microparticle 
in solution, this approach allows much more types of microparticles to be immobilized 
and encoded than the previous approaches. Recently, Barbee et al. [59] developed 
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another chip-based platform for efficient immobilization and encoding of 
microparticles. With the assistance of an external electric field, different types of 
microparticles can be sequentially deposited onto the microelectrode surface with each 
deposition being done in merely tens of seconds, and the microparticles can then be 
encoded with their spatial positions by imaging. The encoding of twenty batches of 
microparticles was demonstrated with ten deposition process and two fluorescence 
encoding dyes. There are three most notable advantages of spatial encoding method 
over other methods: (1) spatial encoding does not require fabrication of specialized 
microparticles or the modification of the microparticles with colors or barcodes, and 
therefore the choice of microparticles can be much more flexible to fit for the 
optimization of biochemical assays; (2) spatial encoding is a more efficient method as 
the encoding process is simultaneously done with the assembly of microparticle array 
while for other encoding methods, the pre-encoding and array fabrication should be 
done stepwise; (3) decoding of microparticles do not require any complicated spectral 
or barcode resolving equipment.  
 
2.3.4 Miscellaneous encoding methods 
Other miscellaneous methods were also developed for the encoding of microparticles. 
Benecky et al. [123] developed multiplexed immunoassay using different sized 
microspheres. A customized particle flow analyzer, which was able to distinguish 0.1 
µm difference in particle diameter, was employed for size based decoding for four 
types of microparticles. However, the fabrication of different types of microspheres 
with well-controlled sizes is very challenging and the available “size codes” could thus 
be limited. In another research work, Evans et al. [112] fabricated shape-encoded SU-8 
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microparticles, named as “FloCode”, which can be decoded by flow cytometry. 
Multiplexed fluorescence DNA hybridization assays were demonstrated with these 
encoded microparticles. Kastl et al. [124] also fabricated different shaped “graticles” 
with grated surface for SPR detection. Label free multiplexed detection for both DNAs 
and proteins was achieved by measuring the SPR signals arisen from shape encoded 
graticles [125]. Nevertheless, the involvement of cleanroom and expensive equipment 
for shaped microparticle fabrication could limit the application of shape encoding 
method.  
While the encoding of microparticles was done either before or during the microarray 
fabrication process for all the above methods, Illumina, Inc. developed a method to 
encode microparticles after the assembly of the microarray [126]. Microparticles with 
different surface oligonucleotide probes were sequentially hybridized and denatured 
with target DNAs which were label with fluorescence dyes (either type of two dyes) or 
were not labelled. Thus, in every hybridization step, each microparticle can obtained a 
code from three possible codes (0 for unlabelled target, 1 for dye A labelled target, 2 
for dye B labelled target.). With eight sequential steps, theoretically 6561 (38) different 
eight-digit ternary codes can be generated, and as an example, 1520 types of these 
codes were used for encoding the microparticles with different oligonucleotide probes. 
Although this method achieved highest multiplexing power among the current 
microparticle arrays, its application is limited to only DNA hybridization assays.  
A summary of the current microparticle encoding methods is demonstrated in Table 
2.2 
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Table 2.2 Summary of the current microparticle encoding methods 
 
 
2.4 Microparticle array for biochemical assays 
Microparticle allows more bioprobes to be immobilized per unit of area and enables 
the three dimensional diffusion of target analytes towards the bioprobes, thus 
microparticle is regarded as an important solid support for biochemical assays [127]. 
The integration of microparticles into microarray embraces the advantages of fast 
kinetics as well as the multiplexing capability, and various biochemical assays have 
been done on microparticle array platforms. In the next session, the recent application 
of microparticle arrays on biochemical assays, especially DNA hybridization assays 
and immunoassays, will be reviewed. 
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2.4.1 DNA hybridization assays 
The attachment of nucleic acids or oligonucleotides onto microparticles’ surface was 
originally used for the application of DNA/RNA separating and purification [128] and 
solid phase sequencing [129]. With the development of solid-phase DNA assay and 
microarray technology, microparticle arrays have been utilized intensively for 
multiplexed DNA hybridization assays. Luminex Corporation and Illumina Inc. are 
two of the most successful companies who developed commercialized microparticle 
arrays for DNA hybridization assays. 
Luminex Corporation developed a suspension microparticle array platform with flow 
cytometry based detection [50]. With this platform, as the reporter fluorescence dye 
has different excitation and emission wavelength with the encoding fluorescence dyes, 
the encoding as well as the quantitation can be done simultaneously using two-laser 
excitation. It has been widely utilized for  multiplexed DNA hybridization assays [38]. 
As an example, Yang et al. [130] reported the expression profiling of 20 genes from 
Arabidopsis thaliana using Luminex suspension microbead array system. The total 
hybridization assay time was only ~1 hr which was much shorter than the time 
required for conventional Affymetrix cDNA microarrays (~16 hrs [131]). Besides the 
expression profiling, the Luminex suspension microparticle-based DNA microarray 
was also employed for the detection of single nucleotide polymorphisms (SNPs) [132], 
the detection of genetic disease [133] and microbial detection [134]. The advantage of 
the Luminex platform is its high flexibility as the microparticles were commercially 
available and can be attached with desired oligonucleotide probes by the customer 
themselves. However, the limitation for Luminex suspension microparticle DNA 
microarray platform is the low multiplexing capability which only allows the 
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simultaneous detection of 100 different target DNA/RNAs which could be not enough 
for genome level analysis. 
Illumina Inc. developed two platforms for the microparticle-based multiplexed DNA 
hybridization assays, named Sentrix Array Matrix and Sentrix Beadchip [8]. The 
Sentrix Assay Matrix integrated etched fiber optical bundles into 96-well plates while 
Sentrix Beadchip utilized etched microwell chip on a silicon substrate. Both platforms 
allow the microparticles to be stably immobilized and encoded after the array assembly 
as discussed in session 2.3.4 and the fluorescence detection were also employed. These 
platforms have been applied for gene expression profiling [135], SNP detection [6] and 
epigenetic profiling [136]. Compared to Luminex suspension microparticle array, 
Illumina platforms have higher multiplexing (>1000 [135]). However, the Illumina 
microparticle arrays are less flexible to be customized by customer themselves. 
Although these two companies have developed matured microparticle array 
technology for high-throughput multiplexed DNA analysis, the cost of the specialized 
instruments is high. Thus, other cost-effective microparticle array platforms have been 
developed for low to mid multiplexing DNA hybridization assays which also found 
their application in scientific research. As an example, Ali et al. [9] developed 
microbead array assembled on etched silicon microwells chips which was integrated 
into a flow chamber system for automatic delivery of DNA samples. The hybridization 
assay time was only 10 min which is much less than the time needed for the 
commercial systems. As an alternative, Wen et al. [34] reported the integration of 
microbead array into microfluidic device for the multiple gene expression detection. 
Each microparticle was separated from each other in microfluidic chambers. The 
hybridization time with this microfluidic microparticle array was only 20 min while 
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the sample volume was reduced to 2 µl. The same platform has been altered for the 
detection of single nucleotide mismatch [137] and cancer gene detection [138]. 
Another cost-effective platform was reported by Ng et al. who employed simple-
fabricated gel pad array chip for the assembly of microparticle array for the 
multiplexed discrimination of bacteria species [5] as well as the diagnosis of genetic 
disease [139]. While the cost of the chip was very low, the DNA hybridization assays 
can be done within 10 min on this platform.  
 
2.4.2 Immunoassays 
The first microparticle-based biochemical assay was the latex agglutination test which 
was based on the agglutination of antibody-coated latex microparticles in the presence 
of the antigens and it was the primitive format of the modern immunoassays [3]. Once 
being integrated into microarray format, microparticle-based immunoassay enables the 
multiplexed detection of target antigens as well as fast reaction time, thus possessing 
superiority over conventional enzyme-linked immunosorbant assay (ELISA) which is 
currently the immunoassay gold standard. Various microparticle array platforms have 
been developed for immunoassays. 
A widely used microparticle array platform for immunoassay is the Luminex xMAP 
suspension platform which employed 100 different dual-color coded microparticles for 
multiplexed immunoassays [50]. The immunoassay could be done in conventional 96-
well plate while the decoding of microparticles is through flow cytometer with two 
laser source, one to simultaneously excite the two encoding dyes, one to excite the 
reporting dye conjugated to the detection antibodies. As different antibodies can be 
conjugated to the microparticles, this platform has been used for the quantitative 
Chapter 2 - Literature Review 
32 
 
detection of various panels of analytes such as cytokines [140], tumor markers [14], 
antibodies [141] and toxins [142]. Nevertheless, for such a commercialized system, the 
expensive dedicated flow cytometer could not be cost-effective for low to mid 
multiplexed immunoassays and the 100 multiplexing capability is not enough for 
proteomic research.  
Another commercialized microparticle array platform for immunoassay is the 
“Veracode” platform developed by Illumina Inc. [77]. This platform employs 
cylindrical glass microparticles encoded with holographic barcodes for multiplexing 
immunoassay. An automated workstation serves to suck the microparticle solution 
from a 96-well plate after the sandwich fluorescence immunoassay reaction and to 
align the microparticles into a groove plate for fluorescence detection. The decoding 
and detection are through the scanning of each microparticle with two laser beams, one 
for the barcode recognition, one for the reporter dye excitation. Theoretically unlimited 
number of codes can be generated with 24-bit of barcodes and the multiplexing 
capability could be very high in this platform.  
For most non-commercialized platforms, the multiplexed immunoassays were usually 
done with encoded antibody-coated microparticles immobilized in certain 
microstrcutures, such as the etched wells on optical fiber bundles [10] or on silicon 
wafer [59, 80], hot-embossed wells on polymer substrate [28] and into the 
microchambers in a microfluidic system [12]. Another strategy is the use of different 
channels to separate antibody-coated microbeads as described by Sivagnanam et al. 
[33]. One special microarray made with clusters of antibody-coated microbeads 
immobilized in alginate gel matrix was recently introduced by Li et al. [11]. The pore 
size of the alginate gel is small enough to trap 1 µm microparticles inside while it is 
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also bigger enough for the free diffusion of antigens and detection antibodies. With 
this microarray, LODs in the range of pg/ml for 6 different protein analytes were 
achieved with the assay time of 3 hrs. Similar strategy was also employed by Ikami et 
al. [143] who fabricated antibody-coated microparticle cluster arrays inside flow 
channels by spatially controlled photopolymerization of polymer solutions containing 
microparticles. Multiplexed detection of three protein markers with LODs at sub-
nanogram per microliter was achieved with the total assay time <10 min. This 
microparticle-based multiplexed and high throughput (simultaneously ~24 assays) 
immunoassay platform could be very promising for point-of-care diagnostics. 
While all the above platforms directly relate the signal intensities of microparticles 
with the concentration of analytes for quantitative immunoassay, Rissin et al. [46] 
developed microparticle-based novel “Digital Immunoassay” platform which relates 
the concentration of analyte with the ratio of fluorescent microparticles to all 
microparticles arrayed on etched optical fiber wells. This platform works based on the 
principle that when the target analyte concentration is extremely low so that the 
number of analyte molecules is less or comparable to the number of the antibody-
coated microparticles, the percentage of microparticles that can capture one analyte 
molecule follows Possion distribution [144]. After a sandwich immunoassay and the 
attachment of a secondary enzyme-conjugated antibody, the percentage of 
microparticles bound with at least one analyte molecule can be visualized by 
converting a non-fluorescent substrate into fluorescent signals in each microwell 
through enzymatic reactions. The great advantage of this method is the capability to 
detect sub-femtomolar of antigens (theoretically, one molecule) which is not possible 
for other microparticle-based immunoassays or conventional ELISA method. This 
platform was applied for the analysis of serum prostate specific antigen (PSA) level for 
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prostate cancer recurrence monitoring [13] and was later integrated into a polymeric 
disc device which allowed the simultaneous analysis of 24 samples [145]. Despite the 
obvious advantage of this microparticle array platform, its inability for multiplexed 
immunoassay could be a limitation and thus it requires further optimization.  
 
2.5 Autonomous microfluidic capillary system  
In conventional microfluidic biochemical assay systems, external pumps such as 
peristaltic pumps and syringe pumps are employed to drive the flow through the 
microchannels. These external pumps serve to control the flow rate thus providing 
both appropriate flow conditions for the assay and consistent flow conditions for the 
reproducibility of the results. However, external pumps are usually bulky and require 
electric power sources which increasing the complexity of the analysis system.   
Several passive pumping techniques have been developed to replace the external 
pumps in microfluidics, such as pumping by absorbance of air in pre-vacuumed PDMS 
microchannels [35, 146], pumping by chemically generated oxygen in sealed chamber 
[37] and pumping by autonomous microfluidic capillary system [36]. Among all these 
techniques, the autonomous microfluidic capillary system could be the most widely 
used method for external-pump-free delivery of liquid in microchannels. The 
following section will review the principle of the microfluidic capillary system as well 
as its state-of-the-art applications in biochemical assays, especially in immunoassays. 
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2.5.1 Working principle of microfluidic capillary system 
An autonomous microfluidic capillary system employs wettable microchannels as well 
as geometries in microchannels to guide the fluid through capillary actions. It is 
originated from the conventional lateral flow test which employs a porous membrane 
as well as filter papers to provide the capillary pressure to drive the fluid. Figure 2.5 
demonstrates a typical microfluidic capillary system fabricated in silicon [147] which 
contains loading elements, capillary retention valve (CRV), flow resistance and the 
capillary pump. In such a microfluidic capillary system, the flow rate of the fluid was 






=            Equation 2.1 
Where Q is the flow rate, ∆Pc is the difference of capillary pressure between the two 
flow fronts (advancing and receding fronts), RF is the flow resistance of the channel 
and η is the viscosity of the flow. For liquid in a closed rectangular microchannel, Pc 
can be calculated by [148]: 
cos cos cos cos( )b t l rcP d w
α α α αγ + += − +        Equation 2.2 
Where γ is the surface tension of the liquid, αb,t,l,r are the contact angles of liquid on the 
bottom, top, left and right surfaces of the channel, d and w are depth and width of the 
microchannel.  




Figure 2.5 A typical microfluidic capillary system. (a) Top view. (b) Cross view 
(From [147]). 
 
The RF of the capillary system is usually accumulated with the length of the channel. 
For a rectangular microchannel, RF can be approximated by the equations below as 
described by Delamarche et al. [147, 148]: 
When w < d: 
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        Equation 2.3 









= +  
  
                        Equation 2.4 
Where d and w are depth and width of the microchannel, rH is the hydraulic radius of 
the microchannel which equals to dw/(d+w), L is the length of the microchannel.  
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In a typical capillary system as shown in Figure 2.5, when liquid is added into the 
loading pad, which is open to air, the capillary pressure of the microchannel enables 
the gradual introduction of liquid into the microchannel. The downstream capillary 
pump element contains microstructures to provide suitable capillary pressure as well as 
to provide enough volume for reagents, while the flow resistance of the system is 
mainly determined by the thin and long microchannel in the middle. The CRV region 
has the highest capillary pressure in the entire system and it thus can act as a valve to 
prevent the drying out of the liquid in the downstream reaction chamber [36]. The flow 
rate in such a capillary system can be programed by: (1) alternation of the geometry of 
the microstructure in the capillary pump (change of capillary pressure); (2) alternation 
of the wettability of the microchannel surfaces (change of capillary pressure); (3) 
alternation of the length of the flow resistor.  (1) and (3) can be achieved simply by 
changing the design of the microfluidic system while (2) can be achieved by altering 
the material as well as the surface modification method of microchannels.  
 
2.5.2 Fabrication of microfluidic capillary system  
As mentioned above, the liquid flow rate in a capillary system is determined by both 
the geometry of the microstructures in microchannels and the wettability of the 
channel surface. Thus, the two key processes during the fabrication of the microfluidic 
capillary system are the microfabrication of microstructures and the surface 
modification.  
The microfabrication process of microstructures for capillary systems is entirely 
compatible with conventional microfabrication process. A research group at IBM 
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Research Lab - Zurich fabricated capillary systems on silicon wafers using standard 
photolithography and deep reactive ion etching (DRIE) to generate microchannels and 
microstructures [36, 147, 149-151]. The advantage for silicon substrate is obvious as 
the dimension of the microstructures can be precisely controlled and the silicon surface 
is compatible with various surface modification process. However, the tedious 
fabrication steps (8 steps [150]) could be a major concern. Alternatively, Åmic AB, a 
Swedish bio-company, fabricated a capillary pump system with a cyclo-olefin 
copolymer (COC) substrate by either injection molding [152] or hot embossing [153] 
which both involve only one-step fabrication processes. The simplified fabrication 
process enabled the company to massively produce the capillary pump chips. Another 
prevailing microfabrication method, soft-lithography, was also employed for the 
fabrication of capillary system as it requires no expensive equipment and is thus more 
applicable to common biolabs. Several research groups reported the fabrication of 
capillary system with PDMS using soft-lithography [154-156]. 
As the capillary system employs hydrophilic surfaces to generate capillary pressures, it 
is required for the stable hydrophilic modification of the microstructure surfaces, 
especially for hydrophobic surfaces. Moreover, when being applied for the 
biochemical assays, the capillary system should also be surface modified with 
biocompatible materials which should also not generate strong interfering background 
signals after the assays. Juncker et al. [36] modified the silicon chip based capillary 
system sequentially with gold and thiolated poly(ethylene glycol) to render a 
hydrophilic and protein repellent surface for the application in immunoassay. This 
method was later simplified by direct immersing of the silicon chip into poly(ethylene 
oxide) solution (Pluronic® F108) which has the similar properties as PEG [149]. Åmic 
AB employed a silane-dextran chemistry to modify the COC based capillary system 
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which turned the surface contact angle of COC from 90° to 30° [152]. The coupled 
dextran molecules not only provided a stable hydrophilic surface (contact angle stable 
for 2 months) but also enabled the coupling with capture antibodies through Schiff 
base reaction for immunoassays. For PDMS based capillary system, the most popular 
surface modification method is oxygen plasma treatment [155]. However, the plasma 
treated PDMS recovers its hydrophobicity quickly in ambient conditions [157] and 
cannot maintain long term stable hydrophilicity. As an improvement, Lillehoj et al. 
[154] coated PEG onto plasma treated PDMS by simple heating, resulting in a stable 
and hydrophilic surface on PDMS based capillary system. With a different approach, 
Thorslund et al. [158] coated a heparin layer onto the PDMS to generate a hydrophilic 
and bioactive surface. The heparin moieties on the surface can be further linked with 
avidin to be coupled to biotinylated reagents for bioassays [156]. Despite the 
availability of these surface modification methods and the simple soft-lithographical 
molding process, PDMS itself is not an ideal material for the fabrication of capillary 
systems due to its intrinsic hydrophobic property. As a substitute material to PDMS, 
Norland Optical Adhesives (NOA) has been used for the fabrication of capillary 
systems [159-161]. NOA based microstructures can be fabricated by UV curing 
against a PDMS coated silicon mold (to prevent the adhesion between NOA and 
silicon surface) or a PDMS mold. The cured NOA has a native hydrophilic surface 
(contact angle ~67° [159]) and its surface can be further treated with oxygen plasma to 
generate even more hydrophilic surface (contact angle ~40° [159]) with long term 
stability. Thus, capillary system fabricated in NOA could require no further surface 
modification process [161] for the generation of capillary pressure which could greatly 
reduce the entire production time.  
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2.5.3 Capillary system for biochemical assays 
The most prominent advantage of a capillary system over a conventional microfluidic 
system for biochemical assays is the autonomous delivery of samples and reagents 
with programmable flow rate of liquid without the need of bulky pumps and energy 
sources. Thus, the capillary system is more suitable for point-of-care assay 
applications which require a simple set-up with minimal manual assay steps.  
So far, the most important application of capillary system is for the autonomous 
immunoassays as enlightened by conventional lateral flow test [162]. In a pioneer 
research, Juncker et al. [36] fabricated a silicon based capillary system for the 
immunoassay of C-reactive protein (CRP). The immunoassay was done with 
sequential introduction of reagents with a total reagent volume of only 3 µl and an 
assay time of 25 min. A similar capillary system was later integrated with micromosaic 
immunoassay for the detection of tumor necrosis factor-α (TNF-α) with a sensitivity of 
20 pg/ml [163]. This silicon capillary system was further advanced by integrating all 
the immunoassay reagents (capture and detection antibodies) and blood filtering 
element into the system which enabled a one-step immunoassay for the detection of 
cardiac marker with merely 5 µl of the whole blood sample (Figure 2.6) [149]. 
Besides the silicon based capillary system, Åmic AB developed COC based 
“4castchip®” for the one-step lateral flow immunoassay of CRP [152]. The chip 
consists of a sample zone, a detection zone and a wicking zone which resemble to the 
sample pad, the detection line and the suction pad in a lateral flow test strip. All these 
three zones contained thousands of hydrophilically modified micropillars for the 
delivery of the sample fluid. While all the above capillary systems only allowed the 
detection of one  




Figure 2.6 A capillary system chip for one-step lateral flow immunoassay. (a) The 
design of the chip. (b) The position and interaction of analytes with detection and 
capture antibodies (dAb and cAb) along different part of the chip (From [149]). 
 
antigen, Wang et al. [161] developed a NOA 63 and glass hybrid chip which can 
simultaneous detect 11 different proteins from the whole blood in a one-step 
immunoassay. The site specific immobilization of 11 different antibodies was achieved 
through the hybridization binding between the surface patterned oligonucleotides to 
the antibodies conjugated with complementary oligonucleotides [164]. The capillary 
pressure was generated by the hydrophilic surface of glass and NOA 63 as well as the 
downstream filter papers. 
In addition to the immunoassay, capillary systems were also utilized to other 
biochemical assays. Hitzbleck et al. [165] recently reported the detection of DNA 
target from PCR product within a capillary system which was integrated with external 
heating element for the melting of the DNA and hybridization of target DNA with the 
oligonucleotide probe. The reaction time was controlled by a capillary soft valve 
which can be manually pressed to allow the reaction mixture to flow through to the 
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downstream detection zone by capillary pressure. Dudek et al. [153] developed a 
capillary system to measure human plasma fibrinogen based on the Åmic 4castchip®. 
Once the plasma was introduced, the thrombin coated onto the chip converted the 
fibrinogen into fibrin and thus causing the clogging of the plasma and the stop of the 
flow. In principle, the distance of the plasma travelled on the chip, which is related to 
the clogging time, is inversely proportional to the concentration of fibrinogen. This 
chip allowed the measurement of fibrinogen in the physiological concentration range 
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Microbead microarray technology has developed rapidly over the recent years and was 
utilized intensively in the bioanalysis field with applications such as genotyping [5, 8, 
166], biomarker detection [10, 47, 167] and pathogen detection [168, 169]. Compared 
to a conventional microarray based on microspots of bioprobes immobilized on a 
planar surface, the microbeads allow more bioprobes to be immobilized per unit of 
area, while they also accelerate the binding kinetics of the biomolecules to the 
bioprobes [4]. Thus, the incorporation of microparticles into microarrays enables faster 
and more sensitive biomolecule detection than conventional planar microarrays. 
Except the suspension microbead microarray which uses microbeads suspended in a 
liquid [38, 50], the majority of state-of-the-art microbead microarrays requires 
immobilization and assembly of microbeads onto certain substrates. However, the high 
mobility of the minute microbeads makes the immobilization of microbeads 
challenging. One of the widely used methods for stable microbead immobilization is 
the physical confinement method [9, 16, 26, 28-30, 70]. The physical confinement 
method, which employs certain microstructures to constrain the microbeads, is a 
straightforward approach to assemble microbeads as the immobilization is not 
dependent on the surface chemistry of the microbeads and no external manipulation, 
such as magnetic force or an electric field, is required. The fabrication methods for 
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these microstructures depend on the substrate material used. With the well-developed 
fabrication methods from the semiconductor industry, a number of research groups 
fabricated silicon based microstructures for the assembly of microbead arrays [16, 21, 
26, 170]. While the standard semiconductor fabrication processes provide precise 
control on the shape and dimension of silicon based microstructures, these fabrication 
processes, which usually involve photolithography and etching, are laborious and 
require specialized cleanroom facilities, expensive equipment as well as intensively 
trained professionals. An alternative to silicon based substrates is fiber optic bundles 
[15]. Well-ordered micrometer-sized wells can be etched out on the distal end of a 
fiber optical bundle [70], thus providing cavities for microbead immobilization. 
However, a slight concern of the customized optical fiber bundles as well as silicon 
substrate is the high cost of material. Recently, several groups reported the fabrication 
of microstructures for microbead assembly with polymeric materials such as cyclic 
olefin copolymer (COC) [28, 145], optical epoxy resin [29] and PDMS [17, 30]. These 
polymeric microstructures provide stable immobilization for microbeads while greatly 
reducing the fabrication cost.  
Another polymeric microstructure for the assembly of microbead arrays is the gel 
based microstructure which was reported recently [5]. As reported, polyacrylamide gel 
based micropad arrays (gel pad arrays) was used for the assembly of polystyrene 
microbead arrays. These gel micropads was fabricated by the UV photopolymerization 
of polyacrylamide prepolymer though a photomask [171]. Neither cleanroom facilities 
nor expensive and sophisticated equipment is needed for fabrication. Furthermore, the 
fabrication of gel pad arrays requires no pre-fabricated molds or masters as compared 
to the fabrication processes for other polymeric microstructures used in microbead 
array assembly, such as hot embossing [28], injection molding [145] and soft-
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lithography [30]. Nevertheless, current application for the microbead array assembled 
on gel pad array is only limited to the semi-quantitative DNA based analysis [5, 139]. 
The potential application of the gel pad array for the assembly of biofunctionalized 
microbead for sensitive and quantitative bioassays, specifically, immunoassays, is not 
explored yet. One obstacle towards employing gel pad array in microbeads-based 
quantitative immunoassay could be the autofluorescence of the polyacrylamide gel 
polymerized using methylene blue as the photoinitiator [172], which could decrease 
the sensitivity of the assay.  
In this chapter, a novel gel pad array chip is developed which was employed for 
sensitive and quantitative microbeads based immunoassays to detect protein markers 
from 1 µl of serum sample. In detail, firstly, the great reduction of autofluorescence of 
gel pad array is demonstrated by using non-fluorescent 2,2-dimethoxy-2-phenylaceto-
phenone (DMPA) instead of strongly fluorescent methylene blue as the photoinitiator 
for the photopolymerization of polyacrylamide gel. Secondly, novel PEG based 
micropillar rings are integrated to the chip to serve as hydrophilic microbarriers for the 
containment of multiple samples. Next, on-chip immunoassays for two model protein 
markers, prostate specific antigen (PSA) and human chorionic gonadotropin (hCG), 
are demonstrated. The reproducibility of the on-chip immunoassay, the stability of 
microbeads on the gel pad array and the reusability of the chip are also discussed. 
Subsequently, we demonstrate the on–chip multiplexed immunoassay for simultaneous 
detection of two protein markers by using spatially encoded microbeads. Lastly, the 
preliminary result is presented for the simultaneous on-chip detection of protein and 
DNA. 
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3.2 Materials and methods  
3.2.1 Materials and reagents 
Microscopic glass slides were purchased from Corning. Polymer spacers were 
purchased from Specac. Sodalime glass chrome masks were all purchased from 
Infinite Graphic. NAP™ 5 columns were purchased from GE Healthcare. Streptavidin-
coated polystyrene microbeads (~10 µm in diameter) were purchased from Bangs 
Laboratory. Acrylamide/Bis-acrylamide solution (40%, 19:1), Poly(ethylene glycol) 
diacrylate (PEG-DA, Mw 575 Da), bovine serum albumin (BSA), N,N,N’,N’-
Tetramethylethylenediamine (TEMED), 3-(Trichlorosilyl) propyl methacrylate (TPM), 
Tween® 20, (+)-Biotin N-hydroxysuccinimide ester (biotin-NHS), 2,2-dimethoxy-2-
phenylaceto-phenone (DMPA), toluene, heptane, methylene blue and recombinant 
hCG were purchased from Sigma-Aldrich. Repel silane (Dimethyldichlorosilane, 2% 
solution in octamethylcyclotetrasiloxane) was purchased from GE healthcare. Ethanol 
was purchased from Fisher Chemicals. Dimethyl Sulfoxide (DMSO) was purchased 
from MP Biomedicals. PBS was purchased from 1st Base. Alexa Fluor 594 NHS ester 
and fetal bovine serum (FBS) were purchased from Invitrogen. PSA, monoclonal anti-
PSA clone 5 antibody, monoclonal anti-PSA clone 7 antibody, monoclonal anti-β-hCG 
clone 1 antibody and polyclonal goat anti-whole hCG antibody were purchased from 
Arista Biologicals. Biotinylated oligonucleotide (seq. 5’ biotin- 
TCACATTTTGGATAATCCCAACC) and Texas Red labelled oligonucleotide (seq. 5’ 
Texas Red-GGTTGGGATTATCCAAAATGTGA) were purchased from Proligo, 
Sigma. Deionized water was produced by Arium® 611 UV system (Sartorius AG, Go). 
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3.2.2 The fabrication of gel pad array chip 
3.2.2.1 The chip design 
The gel pad array chips were fabricated on a microscopic glass slide with the 
dimension of 75 mm (L) x 25 mm (W) x 1 mm (H). The design of the masks was done 
in AutoCAD software (Autodesk). The design of the masks allowed the fabrication of 
40 polyacrylamide gel pad array units (Figure 3.1a) and 40 PEG based micropillar 
rings (Figure 3.1b). The distance between two gel pad array units and two micropillar 
rings were all set to be 4.5 mm so as to be identical with the distance between the two 
wells on a conventional 384-wells plate, thus making the chip compatible with 
commercialized multi-channel micropipettes. Feature for each gel pad array unit 
contains 17 x 17 square gel pads (20 µm x 20 µm) with 10 µm gap (Figure 3.1a). 
Feature for each micropillar ring contains polar array of 20 circles (200 µm in diameter) 
with the total diameter of the array of 2 mm (Figure 3.1b). The entire features on the 
mask design cover an area of approximately 40.5 mm x 13.5 mm which fits well onto a 
microscopic glass slide.  
 
3.2.2.2 Fabrication Process 
The fabrication process of the gel pad array chip consists of three steps: 
(1) Surface modification of the glass slides.  
The glass slides were sequentially cleaned with ethanol, detergent and deionized water. 
They were then treated with 30% H2O2 for 30 min. These glass slides were 
subsequently treated with 5 mM TPM solution (4:1 heptane and chloroform [120]) for 
30 min. The silanized glass slides were cleaned with ethanol and deionized water 
before being stored in a clean microscopic slide storage box.  




Figure 3.1 The mask design for gel pad array chip. Red area is chrome coated and 
black area is kept clear. (a) The design for polyacrylamide gel pad array units. Top: an 
array of gel pad array units. Bottom: a single gel pad array unit; (b) The design for 
PEG based micropillar-rings array. Top: an array of micropillar-ring. Bottom: a single 
micropillar-ring. 
 
(2) Fabrication of polyacrylamide gel pad array units through photopolymerization. 
The mask with features of gel pad array units was pre-treated with Repel Silane for 15 
min to prevent the attachment of polyacrylamide gel. Next, a 10% 
acrylamide/bisacrylamide precursor solution doped with 0.02% (w/v) DMPA and 1.2% 
(v/v) TEMED was transferred into the gap between the photomask and a TPM treated 
glass slides through capillary action. The height of the gap is defined by a pair of 12 
µm mylar spacers. The solution was then UV exposed under a fluorescence 
microscope equipped with a mercury lamp, a 4X magnification lens and a DAPI filter 
(350 nm excitation). The power of the UV light was ~150 mW/cm2. Each gel pad array 
unit was exposed for 1 min which made the total fabrication time of ~40 min. The 
Chapter 3 - Gel pad array chip for microbead-based immunoassay 
49 
 
glass slide with patterned gel pad array was then detached from the mask and washed 
with ethanol and deionized water.  
(3) Fabrication of PEG micropillar-ring array through photopolymerization.  
The mask with features of micropillar-ring array was pre-treated with Repel Silane for 
15 min to prevent the attachment of PEG. The mask was then aligned to the glass slide 
with gel pad array under microscope to make sure each array unit was in the center of 
each micropillar ring. A pair of 150 µm Teflon spacers was used to define the height of 
the gap between mask and the glass slide. The mask-spacers-slide apparatus was then 
clamped from the side to prevent movement. Subsequently, pure PEG-DA pre-
dissolved with 1.5% (w/v) DMPA was transferred into the gap by capillary action. The 
apparatus was then put into a UV crosslinker (365 nm excitation; power of ~4 
mW/cm2) and exposed for 6 s. The glass slide with both gel pad array and micropillar 
ring array was then detached from the mask, washed with ethanol and deionized water. 
The fabricated gel pad array chip was stored in a clean petri-dish and sealed with 
parafilm. 
The schematic fabrication process was shown in Scheme 3.1. The silanization and 
photopolymerization chemistry are shown in Scheme 3.2. The fabricated gel pad array 
chip is shown in Figure 3.2. It contains 40 gel pad array units segregated by the PEG 
micropillar rings. The current chip is designed for the sample volume of 1 µl and the 










Scheme 3.1 Schematic diagram of the fabrication process of gel pad array chip. 
 




Scheme 3.2 The silanization and photopolymerization chemistry. (a) The surface 
silanization of glass slide with TPM. (b) The photopolymerization of acrylamide 
prepolymer on the TPM treated glass slide. (c) The photopolymerization of PEG-DA 








Figure 3.2 Gel pad array chip. (a) Overview. (b) A gel pad array unit with PEG 
micropillar ring around. (c) The gel pad array unit. 
 
3.2.3 Preparation of antibody conjugates  
Monoclonal anti-PSA clone 5 antibody and monoclonal anti-β-hCG clone 1 antibody 
were used as capture antibodies and were conjugated with biotin. The biotinylation 
was done using a modified method from a previous protocol [173]. A 10 mg/ml biotin-
NHS solution (in anhydrous DMSO) was added to the antibody solution (in PBS, with 
0.2-0.5 mg of antibody and a concentration > 1 mg/ml) with 10:1 molar ratio of biotin-
NHS to antibody. The mixture was gently shaked at RT for 2 hrs. The biotinylated 
antibody was separated and purified by using NAP™ 25 columns. The concentration 
of the biotinylated antibody was determined by using a UV2450 spectrophotometer 
(Shimadzu). The biotinylated antibody solution was aliquoted and stored in -20 °C.  
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Monoclonal anti-PSA clone 7 antibody and polyclonal goat anti-whole hCG antibody 
were used as detection antibody and were conjugated with Alexa Fluor 594. A 1 
mg/ml Alexa Fluor 594-NHS solution (in anhydrous DMSO) was added to the 
antibody solution (in PBS, with 0.2-0.5 mg of antibody and concentration >1 mg/ml) 
with 10:1 molar ratio of dye to antibody. The mixture was gently shaked in a dark 
chamber at RT for 2 hrs. The Alexa Fluor 594 conjugated antibody was separated and 
purified by using NAP™ 25 columns. The absorbance of the Alexa Fluor 594 antibody 
was measured by using a UV2450 spectrophotometer (Shimadzu). The concentration 
of the antibody-dye conjugate was estimated based on the equation below as suggested 
by the manufacturer:  
Antibody concentration (M) = 280 590[ 0.56]
203,000
A A− ×
×  dilution factor          Equation 3.1 
 
3.2.4 Preparation of biofunctionalized microbeads 
Streptavdin-coated microbeads (~18000 beads/µl) were washed twice with PBS-B-T 
(1X PBS, 1% BSA, 0.05% Tween® 20) and re-suspended in the same volume of PBS-
B-T as the stock solution. The microbeads solution was then mixed with equal volume 
of biotinylated antibody solution with the final antibody concentration of 0.1 mg/ml. 
The mixture was incubated at RT for 2 hrs. The microbeads were then washed with 
PBS-B-T for 5 times before being re-suspended in PBS and stored at 4°C. 
Oligonucleotide-coated microbeads were prepared as below. Streptavdin-coated 
microbeads (~18000 beads/µl) were washed twice with TE buffer (10 mM Tris, 1 mM 
EDTA, pH 8.0) and re-suspended in the same volume of TE buffer as the stock 
Chapter 3 - Gel pad array chip for microbead-based immunoassay 
54 
 
solution. The microbeads solution was then mixed with an equal volume of 
biotinylated oligonucleotide with the final oligonucleotide concentration of 10 µM. 
The mixture was incubated at RT for 2 hrs. The microbeads were then washed with TE 
buffer for 5 times before being re-suspended in TE buffer and stored at 4 °C. 
 
3.2.5 Contact angle measurement 
The surface hydrophilicity of TPM treated glass slides and polymerized PEG film was 
characterized by using contact angle measurement. The polymerized PEG film (150 
µm thick) was fabricated in the same way as the fabrication for PEG micropillar-ring 
array mentioned in section 3.2.2 except that a Repel Silane treated glass slide rather 
than a mask was used. The contact angle was measured using the static sessile drop 
method with a goniometer (VCA Optima surface analysis system, AST Products Inc.). 
Droplet volume of 0.5 µl and a stabilizing time of 10s were used for all the 
measurements.  
 
3.2.6 On-chip microbead-based immunoassay  
The on-chip microbead-based immunoassay was done in the format of a fluorescence 
sandwich immunoassay (Scheme 3.3).  
For the single-plexed immunoassay for hCG and PSA, the density of the antibody-
coated microbeads in the solution was first adjusted to ~500 beads/µl. 0.1 µl of 
microbeads solution was applied to each gel pad array unit. The deposition of 
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microbeads was achieved by evaporating away all the liquid at room temperature in ~2 
min to affiliate the settlement of microbeads between gel pads. The chip was then 
washed with PBS from the side for 10 s to remove any microbeads which settled 
outside the gel pads array. After the chip was dried under nitrogen gas, 1 µl of each 
FBS sample with target analyte (PSA or hCG) was applied onto each gel pad array unit 
using a single-channel or multi-channel micropipette. The chip was then incubated at 
RT for 30 min in a home-made wet chamber (100% humidity). Subsequently, the chip 
was taken out of the wet chamber and rinsed with PBS-T (1X PBS, 0.05 % Tween® 20) 
for 10 s to remove majority of the sample. Next, the chip was put into a clean petri-
dish filled with 20 ml of PBS-T and was rotated at 60 rpm for 10 min to completely  
remove the non-binding analyte. The chip was then rinsed with PBS and nitrogen gas 
dried. 1 µl of detection antibody in PBS was then applied onto the each gel pad array 
unit and was allowed to be incubated with the microbeads for 30 min in the wet 
chamber. The step to remove excess amount detection antibody is identical to the step 
for the removal of unbinding analyte. After the immunoassay, the chip was imaged by 
using a fluorescence microscope.  
For the multiplexed immunoassay for the simultaneous detection of hCG and PSA, the 
density of the antibody-coated microbeads in the solution was first adjusted to ~200 
beads/µl. Two batches of microbeads, anti-hCG and anti-PSA microbeads were 
sequentially arrayed onto the gel pad array employing the same deposition procedure 
for single-plexed assay. After deposition of first batch of microbeads, each array unit 
was imaged under microscope so as to record the spatial position for every microbead 
on hydrated gel pad array. The following immunoassay procedures were similar to that 
of the single-plexed immunoassay except that FBS samples were spiked with both 
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analytes (PSA and hCG) and the detection antibody solution contained Alexa Fluor 
labelled antibody for both analytes.  
The summary of the on-chip immunoassay procedures was shown in Table 3.1. 
 
 
Scheme 3.3 Schematic diagram for fluorescence sandwich immunoassay. 
 
 
Table 3.1 Immunoassy procedures on gel pad array chip 
Procedures Time 
  On-chip  (Single-plexed) On-chip (Multiplexed) 
Immobilization of microbeads 2-3 min 2-3 min/batch 
Imaging and spatial encoding N/A 5 min/batch  
Sample incubation 30 min 30 min 
Washing  10 min 10 min 
Detection antibody incubation 30 min 30 min 
Washing 10 min 10 min 
Total assay time < 1.5 hrs < 2 hrs (2 batches) 
    < 3 hrs (10 batches) 
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3.2.7 Imaging and data analysis  
All bright field and fluorescence images were taken by a CCD camera (Retiga 4000R, 
Qimaging) mounted on a BX41 Olympus fluorescence microscope (Olympus) 
equipped with a Texas Red filter (560 nm excitation, 595 nm dichroic mirror and 630 
nm emission, Chroma Technology) and a mercury arc excitation source. The exposure 
time for immunofluorescence was kept at 4 s unless otherwise noted. The fluorescence 
intensity was measured by analyzing the pixel values of microparticles with Image J 
software (National Institutes of Health). The SEM images were recorded with a Supra 
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3.3 Results and Discussion 
3.3.1 The gel pad array chip 
3.3.1.1 Choice of the photoinitiator 
 
Figure 3.3 Spectra of methylene blue and DMPA. Concentration of methylene blue is 
0.1 mM in water and concentration of DMPA is 0.1 M in ethanol.  
 
The polyacrylamide gel pad arrays reported previously [5, 139] were all fabricated 
using methylene blue as the photoinitiator. One problem for methylene blue is its 
strong absorbance in the visible region. As shown in Figure 3.3, methylene blue has 
strong absorption from 500 nm to 700 nm while it also has slight absorption in the 
other region of the visible spectrum. The absorbance spectrum of methylene blue 
covers the excitation wavelength for almost all major fluorescence dyes for the 
labelling of bioprobes, for example, Cy3 (550 nm), Cy5 (650 nm), Cy 5.5 (675 nm), 
fluorescein (494 nm), Texas Red (590 nm), Alexa Fluor 488 (495 nm), Alexa Fluor 
546 (556 nm), Alexa Fluor 594 (590 nm) and Alexa Fluor 647 (650 nm). Thus, the 
residue of methylene blue after the polymerization reaction could cause background 
fluorescence of the gel, which will limit the application of gel pad array chip for  




Figure 3.4 Comparison of the gel pad array made with different photoinitiator. (a) 
Array made with methylene blue. (b) Fluorescence image of (a). (c) Array made with 
DMPA. (d) Fluorescence image of (c). Both fluorescence images were taken with the 
same fluorescence microscope with same exposure time (4s). Fluorescence intensity 
on the yellow lines is shown in the right diagram. 
 
sensitive and quantitative biochemical assays. Therefore, it is demanded to utilize a 
low autofluorescent photoinitiator to replace the methylene blue for the 
photopolymerization of polyacrylamide.  
DMPA is a colorless photoinitiator which was reported to be used for the efficient 
photopolymerization of acrylamide [174, 175]. Unlike methylene blue, DMPA has 
almost zero absorption in the visible region as shown in Figure 3.3, thus making it an 
ideal non-fluorescent photoinitiator. The gel pad array made with DMPA showed 
much lower autofluorescence compared with the gel pad array made with methylene 
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blue as demonstrated in Figure 3.4. No change of the morphology of the gel pads was 
observed (Figure 3.4c). Based on these results, DMPA was used as the photoinitiator 
all over this work to substitute methylene blue. 
 
3.3.1.2 PEG micropillar ring array 
For high throughput microarray analysis, the microarray on the substrate should be 
separated by certain micro-barriers to form sub-arrays so as to simultaneously deal 
with multiple samples. A most commonly used substrate for sub-array fabrication is 
the conventional multi-well plate [10, 176-178]. Microwells on the plate serve as 
identical reaction chambers for the sample on each sub-array, thus ensuring 
reproducibility for biochemical assays. The sample volume for this kind of sub-arrays 
is usually >20 µl as determined by the volume of each well. The sample volume could 
be further reduced by fabricating miniaturized hydrophobic/hydrophilic micro-barriers 
for each sub-array. Current methods to define miniaturized barriers including 
photolithographical patterning of hydrophobic/hydrophilic SAMs [179], adhesion of 
teflon multi-hole tapes [180] and wax-pattern imprinting [181]. These methods define 
hydrophilic regions which are segregated by the hydrophobic regions on the substrate 
material to trap the sample liquid. Typically, 1 µl of sample volume is enough to 
perform a multiplexed biochemical assay on each sub-array.  
To integrate certain microbarriers to separate each gel pad array unit on the glass chip, 
we employed a new approach using PEG-DA for the photo-patterning of hydrophilic 
microbarriers. There are several advantages for the use of PEG-DA as the patterning 
material: 




Figure 3.5 Entrapment of liquid inside PEG micropillar rings. (a) 1 µl of PBS buffer 
trapped in five different micropillar rings on the chip. (b) 1 µl of FBS trapped in five 
different micropillar rings on the chip. Scale bars represent 500 µm. (c) The side view 
of trapped liquid. Left: PBS. Right: FBS. The arrows indicate the edge of the PEG 
micropillars rings. Dashed lines indicate the glass surface.  
 
 
Figure 3.6 Surface contact angle of TPM treated glass slide and PEG surface over 2 
months’ time. Each error bars represent one standard deviation of 15 measurements on 
three glass slides or PEG surfaces. 
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(1) The photo-patterning of PEG-DA is a well-established technique [182] which 
requires less optimization of the formulation. 
(2) The photo-patterning of PEG-DA is a rapid process which only requires seconds’ 
time. 
(3) No extra surface modification process is required for the glass slides as PEG-DA 
can be covalently photo-crosslinked with TPM coated surfaces. 
(4) The crosslinked PEG has small pore size (~1 nm [119]) which can prevent the 
antigens as well as antibodies to diffuse in. 
(5) PEG is a protein-resistant material [183, 184] which can minimize the unspecific 
surface absorption of either antigens or antibodies during the immunoassay process. 
In addition to these advantages, polymerized PEG surface (contact angle of ~40º) is 
more hydrophilic than TPM treated glass surface (contact angle of ~70º), which makes 
it possible to trap sample liquid and other aqueous reagents within the area as defined 
by PEG micropillar rings. As shown in Figure 3.5, both PBS buffer and FBS can be 
trapped inside the PEG based micropillar rings. The trapped FBS spreads a little 
further than the PBS as the FBS has the lower surface tension than PBS. For both PBS 
and FBS, the shapes of the liquid inside different micropillar rings are almost identical. 
Therefore, the segregated and identically shaped sample liquid and reagent liquid 
ensured the consistency of the experimental conditions for biochemical assay on each 
gel pad array unit. Moreover, both PEG surface and TPM treated glass surface are 
stable as indicated in Figure 3.6 by the surface contact angle measurements over 2 
months’ time. The good surface stability ensures the long-time storage of the chip 
without change of the assay performance. 
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3.3.1.3 Microbeads immobilization on the gel pad array 
In conventional planar microarrays, the bioprobes were spotted or printed onto the 
substrate [1] with their position defined by programing the x-y stages on the 
microarrayer. These arrayers are usually bulky and expensive. For our gel pad array 
chip, nevertheless, the deposition of the microbeads can be done by simple pipetting. 
Usually 0.1 µl of microbeads solution is enough to cover one gel pad array unit (~500 
µm x 500 µm) and 4 µl of microbeads solution is enough for each chip.  
The process of assembling microbeads on a gel pad array is shown in Figure 3.7. After 
the solution was applied to gel pad array, microbeads randomly settled down in 
different positions such as in the cross-point of four gel pads, on the micro-trench 
between two gel pads or on the surface of gel pads (Figure 3.7a left). With the gradual 
evaporation of the solution, the liquid level dropped and the surface tension forced the 
microbeads to move from metastable positions, the micro-trench and surface of the gel 
pad, to the stable positions, the cross-points, as shown in Figure 3.7a (middle). Finally, 
after the solution was completely evaporated, most of the microbeads settle in the 
cross-points as shown Figure 3.7a (right). An interesting phenomena is the 
deformation of the gel pads by the microbeads after the evaporation of the liquid as 
shown in both microscopic image (Figure 3.7a right) and SEM images (Figure 3.7b). 
The deformation of the gel pads indicated the strong interaction between the 
polyacrylamide gel and the biofunctionalized polystyrene microbeads, thus, the 
mechanism for the microbeads immobilization on the gel pad array could be a 
combination of physical entrapment and physical adhesion.  
 




Figure 3.7 Immobilization of microbeads onto the gel pad array. (a) Left: random 
settlement of microbeads; middle: settlement of microbeads in cross-points; right: after 
complete evaporation of solution. Scale bars represent 20 µm. (b) SEM images of dried 
gel pad array unit with microbeads. Scale bars represent 100 µm for the left image and 
5 µm for the right image. (c) Schematic diagram for microbead immobilization on the 
gel pad array. 
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3.3.2 On-chip single-plexed immunoassay for hCG and PSA 
3.3.2.1 hCG and PSA 
Human chorionic gonadotropin (hCG) and prostate specific antigen (PSA), two of 
important protein tumor markers [185], were chosen as target analytes in this study.  
hCG is a 36.7 kDa glycoprotein with 2 subunits, an α subunits with 92 amino acids and 
a β subunits with 145 amino acids [186]. It is produced in high concentration by 
placental trophoblasts during the pregnancy periods [187]. Thus, hCG has been widely 
used as the major protein marker for the test of pregnancy. hCG levels can also been 
elevated in men and in non-pregnant women with tumor. The elevated serum hCG 
level can be an indicator of trophoblast cancer and ovary cancer in non-pregnant 
women, while it also can be an indicator of testicular cancer in men [187]. As the cut-
off serum hCG level is very low (5 - 10 IU/l, or 0.5 – 1 ng/ml [188]), immunoassays 
with high sensitivity are required to measure the hCG for the diagnosis of cancers 
[188]. The commonly used detection devices for hCG are the lateral flow pregnancy 
test strips which are of low cost and easy to use. However, these lateral flow test strips 
usually have limit of detections (LODs) in the range of 25 – 100 IU/l [189] which are 
not low enough for the application in cancer diagnosis. The immunoassay gold 
standard ELISA, is a much more sensitive method for the detection of hCG [190]. 
However, ELISA is usually laborious and require relatively big amount of sample 
(~100 µl) and big quantity of antibody (0.1 µg/ microplate well).  
PSA is a 34 kDa glycoprotein which is specifically produced from the prostate gland 
and has protease activity [191]. The function of PSA in healthy men is to liquefy the 
semen in the seminal coagulum thus giving sperm freedom to swim [192]. PSA is 
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widely used for the diagnosis of prostate cancer as its level elevates in the serum of 
patient [193]. The widely used cut-off PSA level is 4 ng/ml and patients with serum 
PSA >4 ng/ml are considered suspicious for prostate cancer [194, 195]. The current 
gold standard for the measurement of PSA is also ELISA [196] which also suffered 
from the limitations as discussed before. 
 
3.3.2.2 Quantitative immunoassay for hCG and PSA in serum 
The performance of the on-chip immunoassay was first evaluated by on-chip 
microbead-based quantitative immunoassays for hCG and PSA. All the samples were 
prepared by spiking either hCG or PSA in non-diluted FBS to mimic the condition in 
real human serum. The calibration curves were generated by measuring the average 
fluorescence intensity of microbeads after the on-chip assay for serial dilutions of hCG 
(0.0625, 0.125, 0.25, 0.5, 1, 2 and 4 ng/ml) and PSA (0.125, 0.25, 0.5, 1, 2, 4 and 8 
ng/ml). Blank FBS samples were used as zero concentration samples. The calibration 
curves for hCG and PSA is shown in Figure 3.8. Each error bar indicates one standard 
deviation of three individual experiments for sample with the same analyte 
concentration. As shown in the calibration curves, for both hCG and PSA, the 
fluorescence intensity is proportional to the concentration of the analyte. Good 
linearity of the calibration curves are obtained for both hCG (R2 = 0.9993, sensitivity = 
9.5011 a.u./ng · ml-1) and PSA (R2 = 0.9991, sensitivity = 5.0661 a.u./ng · ml-1). The 
assay LODs were determined to be 42 pg/ml (1.1 pM or 0.38 IU/l) for hCG and136 
pg/ml (4 pM) for PSA as calculated by adding 3 S.D. to the measured mean value of 
the blank measurement. The assay LOQs were determined to be 82 pg/ml (2.2 pM or  




Figure 3.8 On-chip immunoassay calibration curve for (a) hCG and (b) PSA in FBS. 
 
0.75 IU/l) for hCG and 194 pg/ml (5.7 pM) for PSA as calculated by adding 6 S.D. to 
the measured mean value of the blank measurement. As the cut-off values of hCG and 
PSA for cancer diagnosis are 5-10 IU/l (0.55 - 1 ng/ml [188]) and 4 ng/ml [194] 
respectively, the LODs of our on-chip assay for both tumor marker is at least one order 
lower than the cut-off value. Compared with the conventional ELISA method for hCG 
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[197, 198] and PSA [196, 199, 200], our microbead-based on-chip immunoassays have 
comparable LODs as well as sensitivities while require much less sample (1 µl vs. 50 – 
100 µl), much less consumption of detection antibody (1 µl vs. 100 µl) and much less 
capture antibody (antibody on surface of less than 100 microbeads vs. antibody on the 
96 or 384 well plate). Considering the sample volume of 1 µl, the on-chip 
immunoassay is actually capable for the detection of merely 1.1 amol (10-18 mol) of 
hCG and 4 amol of PSA.  
 
3.3.2.3 Reproducibility of on-chip immunoassay 
The reproducibility of the on-chip microbead-based immunoassay was evaluated by 
the intra- and inter-assay coefficient of variation (CV). The CVs were calculated by 
dividing the mean of 8 measurements by the variation of these 8 measurements. Each 
measurement was the average fluorescence intensity of all the microbeads on one gel 
pad array unit. For intra-CV, the same sample was applied to 8 gel pad array units on 
the same chip while for inter-CV the sample was applied to 8 gel pad array units on 8 
different chips. The 1 ng/ml of hCG and 4 ng/ml PSA were used in the evaluation of 
CVs as these two concentrations are the cut-off concentrations for cancer diagnosis. 
The results of the reproducibility test are shown in Figure 3.9. The intra-assay CVs for 
hCG and PSA were 4.8% and 6.5% while the inter-assay CVs for hCG and PSA were 
8.8% and 12.0%. The low intra- and inter-assay CVs indicated the good 
reproducibility of the on-chip immunoassay which could contributes to the consistent 
shape and size of the samples defined by the PEG micropillar-rings. These CVs are 
comparable to that of the ELISA methods [196-200] as well as the state-of-the-art 
microbead-based immunoassay systems [10, 14, 47].  




Figure 3.9 The reproducibility of the on-chip immunoassay. (a) The intra- (left) and 
inter-assay (right) CV for immunoassays for 1 ng/ml hCG. (b) The intra- (left) and 
inter-assay (right) CV for immunoassays for 4 ng/ml PSA. Error bars represent 1 S.D. 
for average fluorescence intensity of microbeads on each gel pad array unit. 
 
3.3.3.4 On-chip stability of antibody-coated microbeads  
The gel pad array has been proved to provide stable immobilization of oligonucleotide 
coated microbeads [5]. However, whether the stable immobilization is applicable to 
antibody-coated microbeads remains unknown. The stability of antibody-coated 
microbeads on the gel pad array during the assay could be very important if the chip is 
going to be used for multiplexed microbead-based immunoassay using spatial 
encoding method (discussed in later section). The on-chip stability of microbeads was 
calculated by counting the number of microbeads on each gel pad array unit before and 
after the assay. Each type of antibody-coated microbeads deposited on 24 gel pad array 
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Table 3.2 Stability of antibody-coated microbeads on gel pad array unit 
Bead Type          No. of microbeads 
 Before Assay After Assay Stability (%) 
anti-hCG beads 930 928 99.8 
anti-PSA beads 648 643 99.2 
 
 units was counted before and after the assay. As shown in Table 3.2, more than 99% 
of microbeads remained on the gel pad array after the immunoassay. The result 
indicates that the interaction between the polyacrylamide gel and the protein-coated 
polystyrene microbeads is strong enough to sustain the microbead after the multiple 
washing steps during the immunoassay procedures. Moreover, the position of each 
microbead remains unchanged after the assay. One sample is shown in Figure 3.10 
with anti-hCG microbeads. The unchanged position of each microbead actually can be 
used as an addressable code which allows the spatial encoding of microbeads for 









Figure 3.10 Microbeads on a gel pad array (a) before and (b) after the immunoassay. 
Microbeads shown here are anti-hCG microbeads. Scale bars represent 50 μm.  
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3.3.3 On-chip multiplexed immunoassay for hCG and PSA 
3.3.3.1 Spatial encoding of microbeads on gel pad array 
As discussed in Chapter 2, the spatial encoding method uses the spatial position of 
each microbeads for the encoding/decoding process [5, 59], thus eliminating the need 
for color encoding or barcode encoding which involve either complicated fabrication 
process for microbeads or the expensive or highly specific equipment for readout. The 
prerequisite for spatial encoding is the stable immobilization and patterning of 
microbeads which do not change their spatially encoded addresses during the bioassay 
process. As mentioned previously, the antibody-coated microbeads showed great 
stability on gel pad array during the on-chip immunoassay process. Thus, the simple 
and straightforward spatial encoding method will be an ideal encoding method for our 
microbead-based multiplexed immunoassay.  
By using microbeads with low density in the solution, we demonstrated the spatial 
encoding of 10 batches of protein (streptavidin) coated microbeads in Figure 3.11. As 
can be seen, no microbead loss or change of position was observed during the entire 
deposition and encoding process. Although the density of microbeads was reduced to 
~100 beads/µl, there were still enough beads in each batch (0.1 µl) to provide the 
redundancy (> 5 beads) to give statistically significant results. Theoretically, more than 
400 batches (40 gel pad array units x 10 batches) of different microbeads can be 
encoded on each chip, thus providing significant multiplexing capability. The 
recognition of each batches of microbeads is also possible to be automated by using 
image recognition software [201]. 
 




Figure 3.11 Spatial encoding of 10 batches of protein (streptavidin) coated microbeads. 
 
3.3.3.2 Multiplexed immunoassay for hCG and PSA 
Multiplexed immunoassay was performed using both anti-hCG and anti-PSA 
microbeads. As shown in Figure 3.12a and b, the two batches of microbeads were 
sequentially deposited onto the gel pad array unit with images taken after each 
deposition step for spatial encoding. After the assay for the sample spiked with cut-off 
concentrations of hCG and PSA, while no microbeads loss was observed, all the 
microbeads showed strong fluorescence (Figure 3.12c). Furthermore, thanks to the 
spatial encoding method, the fluorescence signals from both types of microbeads were 
detected using merely one Texas Red emission and detection filter set. This could 
enable the readout of a microbead microarray for multiplexed protein analysis using a 
simple, one-filtered fluorescence microscope which is affordable to most biochemistry 
labs.  
The cross-reactivity of the hCG and PSA immunoassay was also examined by 
performing immunoassay with FBS samples spiked with different combinations of the 
two analytes. Figure 3.13a demonstrates the results from the immunoassays with  




Figure 3.12 Multiplexed immunoassay for hCG and PSA. (a) Deposition of anti-hCG 
microbeads. (b) Deposition of anti-PSA microbeads which are arrowed out. (c) The 
fluorescence image after the assay. The sample contained 1 ng/ml of hCG and 4 ng/ml 
of PSA. Scale bars represent 50 µm.  
 
spiked with fixed cut-off concentration of hCG (1 ng/ml) and 4X serial dilution of PSA 
(0, 0.5, 2, 8 ng/ml) while Figure 3.13b demonstrates the results from the 
immunoassays with samples spiked with fixed cut-off concentration of PSA (4 ng/ml) 
and 4X serial dilution of hCG (0, 0.25, 1, 4 ng/ml). Each error bar represents one 
standard deviation of three individual experiments for the same sample. As shown in 
the Figure 3.13, the linearity of signals for PSA (R2 = 0.9996) and hCG (R2 = 0.9995) 
was not distorted in the presence of the other analyte in the sample. Moreover, the 
signals from the cut-off concentration of PSA and hCG remained consistent in the 
presence of the other analyte. These results indicate the high specificity of the 
antibodies used in this study which minimized the cross-reaction between the two 
analytes. Thus, our on-chip multiplexed immunoassay system could be used for the 
measurement of hCG and PSA in human serum samples for cancer diagnosis. By 
integrating antibody pairs for other protein disease markers, our on-chip immunoassay 
could be promising for the serodiagnosis of various diseases. Compared to the 
multiplexed protein microarray fabricated on 96-well plate [10, 178], the advantages of 
our chip are the less sample volume (1 µl vs. 100 µl) as well as the simpler method to 




Figure 3.13 Testing the cross-reactivity of hCG and PSA by multiplexed 
immunoassay. (a) Immunoassay for samples with 1 ng/ml of hCG and serial dilution of 
PSA. (b) Immunoassay for samples with 4 ng/ml of PSA and serial dilution of hCG. 
 
assemble the array (micropipette vs. microarray spotter). Recently, several groups 
reported the used of multi-microwell planar protein microarray chips which required 
small sample volume (1 µl to 1.5 µl) comparable to this study for each assay [180, 202, 
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203]. However, unlike our gel pad array chips which allow detection of multiple 
analytes in one array unit, all of these studies are only restricted to the detection of one 
analyte in each microwell.  
 
3.3.4 Reusability of the gel pad array chip 
 
Figure 3.14 Reuse of the chip by removing polystyrene microbeads. (a) Microbeads 
on a gel pad array. (b) After immersed in toluene for 10 min. (c) After subsequent 
sonication for 10 min. (d) Reload the gel pad array with a new batch of microbeads. (e), 
(f) and (g) are the enlarged pictures of (a), (b) and (c). Scale bars represent 50 µm for 
(a), (b), (c) and (d), 20 µm for (d), (e) and (f).   
 
Besides the fact that the gel pad array chips were fabricated with simple procedures 
and very low material cost (< S$ 0.2/chip), the chip can be further reused by removing 
the old microbeads and subsequently applied with a new batch of microbeads. As the 
gel pad array provides stable immobilization of microbeads, it is difficult to remove all 
the microbeads through simple rinsing or sonication. To reuse the gel pad array, we 
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removed the microbeads by swelling and dissolving microbeads in toluene with the 
affiliation of sonication. As shown in Figure 3.14, antibody-coated polystyrene 
microbeads can be swelled by toluene (Figure 3.14f) and can be completely removed 
after 10 min of sonication in toluene (Figure 3.14g). A new batch of microbeads can 
then be applied for the reuse of the chip (Figure 3.14d). The deformation of the gel 
pads by the microbeads can still be observed after the reuse of the chip which indicates 
the strong interaction between the microbeads and the polyacrylamide gel is not 
weakened after sonication in toluene. 
The reusability of the chip was also tested by generating the calibration curves for hCG 
in FBS sample on the same reused chip. The chip was reused for two times to generate 
three calibration curves for hCG. The three calibration curves are shown in Figure 
3.15 with each error bar representing one standard deviation of three individual 
experiments for the samples with the same concentration. The linearity of the 
calibration curves are not compromised by the reuse of the chip as indicated by the R2 
value (R2 value: 1st use = 0.9993, 2nd use = 0.9938, 3rd use = 0.9992.). The CV of the 
sensitivity of the three calibration was 4.4% (Sensitivity: 1st use = 9.5011 a.u./ng · ml-1, 
2nd use = 8.9103 a.u./ng · ml-1; 3rd use = 8.7358 a.u./ng · ml-1) which indicated a small 
variation between the immunoassay sensitivity on the reused chip. The stability of the 
microbeads was also tested by counting the anti-hCG microbeads on the gel pad array 
unit before and after the assay in the each reuse of the chip. As shown in Table 3.3, 
more than 98% of the microbeads remained stable on the gel pad array in a third time 
immunoassay on the same chip. All these results prove that the gel pad array chips can 
be robustly reused for the quantitative and sensitive microbead-based immunoassay, 
which is rarely reported in other planar or microbead microarray platforms. The 
reusability of the chip can further reduces the chip material cost for each immunoassay 
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(< S$ 0.2 per chip with < S$ 0.005 per assay on each array unit and with < S$ 0.002 
per assay if with two reuse.). Thus, our chip could potentially be used for the low-cost 
disease diagnosis in developing countries. 
 
Figure 3.15 Calibration of hCG on the reused chip. (a) The calibration curve obtained 
from the same chip with two times reuse. (b) The calibration curve for low 
concentration of hCG (0 – 1 ng/ml). 
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Table 3.3 Stability of anti-hCG microbeads on the reused chip 
 
         No. of microbeads  
  Before Assay After Assay Stability (%) 
1st use 930 928 99.8% 
2nd use 795 787 99.0% 
3rd use 972 958 98.6% 
 
3.3.5 Simultaneous detection of protein and DNA: Preliminary results 
DNA hybridization assay and immunoassay are both binding based assays which rely 
on the specific binding of bioprobes (oligonucleotides and antibodies) with target 
analytes (oligonucleotide and antigens). As the gel pad array provides stable 
immobilization for both oligonucleotide [5] and antibody coated microbeads, it is 
possible to combine the hybridization assay with immunoassay for simultaneous 
detection of protein and DNA using spatially encoded microbeads. 
One possible challenge towards the integration of hybridization assay and 
immunoassay is the different buffer systems. For DNA hybridization, SSC buffer and 
formamide are usually used while, for immunoassay, PBS buffer is most commonly 
used. In this study, we chose the PBS buffer as it has been proved in several studies to 
be compatible with DNA hybridization assay [204-207]. The hybridization assay was 
tested using oligonucleotide probe conjugated microbeads  (seq. 5’ biotin- 
TCACATTTTGGATAATCCCAACC)  to detect the a serial dilution (100 pM – 1 µM)  
of target oligonucleotide (seq. 5’ Texas Red-GGTTGGGATTATCCAAAATGTGA, a 
part of the cDNA sequence from the RNA-dependent RNA polymerase gene in SARS 
coronavirus [208]) in PBS as shown in Figure 3.16. The incubation time was 30 min. 
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Each error bar represents one standard deviation of three individual experiments for 
samples with the same target oligonucleotide concentration. The results indicated a 
proportional relationship between the intensity of the microbeads to the concentration 
of the target analyte. This further proves the compatibility of PBS buffer to the 
quantitative hybridization assay.  
As a proof of concept, we performed a simultaneous immunoassay for hCG and 
hybridization assay for target DNA. 100 ng/ml of hCG and 100 nM of target 
oligonucleotide were spiked in PBS as the sample. The assay procedures were similar 
to that of the on-chip immunoassay despite that PBS was chosen instead of FBS. As 
shown in Figure 3.17, while there was no bead loss or change of position during the 
assay as expected, both anti-hCG and oligonucleotide microbeads showed fluorescence 
after the assay. It is also noticeable that, by using fluorescence label with similar 
excitation and emission spectrum (Alexa Fluor 594 and Texas Red), the simultaneous 
detection of the two kinds of biomolecules can also be done through one-filter set 
fluorescence microscope. Compared with a recent report [125] for the simultaneous 
detection of DNA and protein using biofunctionalized microparticle with SPR 
detection method, our chip based approach is simpler and with much less sample 
consumed although the SPR approach had the advantage of label-free detection. One 
potential application of our on-chip simultaneous immunoassay and hybridization 
assay could be the combination of genomic analysis [6] with proteomic analysis [122, 
209] using microbeads conjugated with different oligonucleotide and antibody probes.  




Figure 3.16 On-chip hybridization assay calibration curve. 
 
 
Figure 3.17 Simultaneous immunoassay and hybridization assay for hCG and target 
DNA. (a) Deposition of anti-hCG microbeads. (b) Deposition of oligonucleotide 
microbeads which are arrowed out. (c) The fluorescence image after the assay. Scale 
bars represent 50 µm. 
 
3.4 Conclusion 
In this chapter, we presented a novel gel pad array chip for microbeads-based 
immunoassays. The previous protocol for gel pad array fabrication was first optimized 
by substituting the strongly fluorescent methylene blue with non-fluorescent DMPA as 
the photoinitiator, thus greatly reducing the background autofluorescence of the 
polyacrylamide gel. In addition, we integrated novel PEG micropillar rings into the 
chip to provide hydrophilic barriers to segregate both FBS samples and other reagents. 
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The optimized gel pad array chip has 40 gel pad array units and allows the biochemical 
assay to be performed with merely 1 µl of sample on each array unit. On-chip 
quantitative immunoassays for hCG and PSA in serum samples were performed with 
the LODs determined to be 42 pg/ml for hCG and 136 pg/ml for PSA. Both LODs are 
lower than the cut-off level for hCG (1 ng/ml) and PSA (4 ng/ml) as serum tumor 
markers for cancer diagnosis. The on-chip immunoassays also showed good 
reproducibility as demonstrated by the small intra- and inter-CVs which are less than 
12%. Moreover, more than 99% of the antibody-coated microbeads remained their 
position during the assay process. The great stability of the microbeads allowed the 
multiplexed immunoassay for both hCG and PSA to be performed on-chip using 
spatial encoding strategy. As up to 10 batches of microbeads can be sequentially 
deposited onto each gel pad array, the multiplexed ability of the chip could be 
potentially increased by immobilization of more batches of microbeads with different 
antibodies. The reusability, which was rarely reported in other microarray systems, 
was also demonstrated. The microbeads on the reused chip still remained high stability 
(> 98%) and the sensitivity of the on-chip immunoassay was not compromised during 
the reusing process. Lastly, as a proof of concept, we demonstrated the on-chip 
multiplexed detection of two different types of biomolecules, protein and DNA, which 
could further expand the application of our chip. As our chips were fabricated at low 
material cost without the requirement for any cleanroom facilities and expensive 
equipment, it could either be used as a platform for the DIY of microbead array in 
common biolabs or be potentially used as a low cost disease diagnosis tool in 
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4.1 Introduction 
The recent development of microfluidic analysis system, also known as micro-total-
analysis-system (µTAS), provides new platforms for biochemical assays [210-212]. 
Owing to the fast mass transfer rate in miniaturized microchannels, microfluidic 
systems enable the biochemical assays to be done with much less sample volume and 
much shorter time as compared to the conventional bioanalytical methods [213, 214]. 
One of the major formats of microfluidic biochemical assay is the heterogeneous assay 
which integrates certain solid substrate in microchannels for the immobilization of 
bioprobes. The immobilized bioprobes, such as oligonucleotides [215], antibodies [152, 
216] and enzymes [217], can either capture or react with the target biomolecules in the 
microfluidic channels and subsequently produce signals for the quantitation. 
Microparticle has been widely used as a solid substrate in microfluidic biochemical 
assays [9, 31, 218, 219]. There are several advantages to utilized microparticles instead 
of other planar solid substrates for microfluidic biochemical assays: (1) microparticles 
allow more bioprobes to be immobilized per unit area, thus increasing either the 
binding capacity or reactivity with the target biomolecules and resulting in the 
enhancement of the quantitation signals; (2) the minute biofunctionalized 
microparticles can be directly incorporated into miniaturized microfluidic systems by 
simple injection [17] or pipetting [28] without any specialized micropatterning [220] 
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or delivering techniques [149] which are required to fabricate planar biofunctionalized 
substrates to be integrated a microfluidic system; (3) microparticles with various 
surface chemistries can be separately attached with different bioprobes and can be 
simply incorporated to the microfluidic system later on [59, 218] whereas it is more 
challenging to integrated planar substrates with different surface chemistries and 
different bioprobes into one microfluidic systems. Due to these obvious advantages, 
microparticle has been integrated into microfluidics for various kinds of biochemical 
assays with three most notable ones, the immunoassays [27, 29, 59, 221-223] , DNA 
hybridization assays [9, 218, 224, 225] and enzymatic assays [39, 226]. Moreover, 
multiplexed microfluidic assays were also achieved by using biofunctionalized 
microparticles which are either encoded or are immobilized in different microchannels 
[32, 33]. Nevertheless, while most of current microfluidic microparticle-based assays 
are able to detect multiple biomolecules of one category (e.g. different proteins, DNAs 
or small metabolites), few have been demonstrated for the detection of different 
categories of biomolecules (e.g. proteins and small metabolites).  
In Chapter 3, as a proof-of-concept, we demonstrated the multiplexed microbead-
based assay for two categories of biomolecules, protein and DNA, on the gel pad array 
chip. While the integration of immunoassay and DNA hybridization assay, which are 
both binding based assays, could be achieved simply using microbeads with different 
surface bioprobes, the integration of binding kinetic based assay and reaction kinetic 
based assay (e.g. enzymatic assays) could be more challenging due to the intrinsically 
different assay mechanisms. In this chapter, the final aim is to develop the microfluidic 
microparticle-based assay which integrates both binding kinetic based immunoassay 
and reaction kinetic based enzymatic assay for the detection of different categories of 
biomolecules. To achieve this, the stability of different biofunctionalized 
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microparticles under microfluidic flow conditions is first tested. Subsequently, the 
microfluidic microbead-based immunoassays for serum samples are developed by 
integrating the existing gel pad array platform. Multiplexed microfluidic 
immunoassays are also demonstrated by using spatially encoded microbeads. 
Furthermore, PEG based microparticles, which contain glucose oxidase (GOx) and 
horseradish peroxidase (HRP), are fabricated for the enzymatic assay for glucose. A 
novel gel well array is developed to affiliate the immobilization of enzyme-containing 
microparticles. Next, the microfluidic enzymatic glucose assay is performed with both 
PBS and FBS samples. Lastly, by immobilizing both antibody-coated microbeads and 
enzyme-containing microparticles on a novel mixed gel microstructure chip, we 
demonstrate the simultaneous detection of proteins and glucose by integrating both 
microfluidic immunoassay and enzymatic assay. To the best of our knowledge, this is 
the first report for the integration of binding kinetic based biochemical assay and 
reaction kinetic based biochemical assay into one microfluidic microparticle array 
platform. 
 
4.2 Materials and methods  
4.2.1 Materials and reagents 
Microscopic glass slides were purchased from Corning. Polydimethylsiloxane (PDMS) 
prepolymer (Sylgard 184) was purchased from Dow Corning. All the hard and soft 
masks were purchased from Infinite Graphic. Silicon wafers were purchased from 
University Wafer. SU-8 50 negative photoresist and SU-8 developer were purchased 
from Microchem. The 10 µm streptavidin-coated polystyrene microbeads were 
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purchased from Bangs Laboratory. Alexa Fluor 594 NHS ester and fetal bovine serum 
(FBS) were purchased from Invitrogen. Prostate specific antigen (PSA, from human 
seminal fluid), monoclonal anti-PSA clone 5 antibody, monoclonal anti-PSA clone 7 
antibody, monoclonal anti-β-hCG clone 1 antibody and polyclonal goat anti-whole 
hCG antibody were purchased from Arista Biologicals. Recombinant hCG, 
acrylamide/Bis-acrylamide solution (40%, 19:1), Poly(ethylene glycol) diacrylate 
(PEG-DA, Mw 575 Da), glucose oxidase (GOx, from Aspergillus niger, type X-S, 
158900 U/g solids), horseradish peroxidase (HRP, from horseradish, type II, 188000 
U/g solids), trichloro(1H,1H,2H,2H-perfluorooctyl) silane, bovine serum albumin 
(BSA), N,N,N’,N’-Tetramethylethylenediamine (TEMED), Ampliflu Red, Tween® 20, 
3-(Trichlorosilyl) propyl methacrylate (TPM), (+)-Biotin N-hydroxysuccinimide ester 
(biotin-NHS), DMPA, toluene, heptane and recombinant hCG were purchased from 
Sigma-Aldrich. Repel Silane (Dimethyldichlorosilane, 2% solution in 
octamethylcyclotetrasiloxane) was purchased from GE Healthcare. Deionized water 
was produced by Arium® 611 UV system (Sartorius AG). 
 
4.2.2 Fabrication of gel microstructure chips 
4.2.2.1 The chip design 
All the gel microstructures were fabricated on the same microscopic glass slides used 
for the gel pad array chip discussed in Chapter 3. The design of the masks was done 
in AutoCAD software (Autodesk). The design of the mask allows the fabrication of 8 
gel microstructure units as shown in Figure 4.1a. The distance between two gel 
microstructure units was set to be 14 mm to leave enough space for the capping of 
microfluidic modules on each array unit. Three types of microstructure array units 
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were designed: (1) gel pad array unit, with 17 x 17 square gel pads (20 µm x 20 µm) 
with 10 µm gap (Figure 4.1b); (2) gel well array unit, with 6 x 6 gel wells (60 µm of 
diameter) with 110 µm distance between two wells (Figure 4.1c); (3) mixed structured 
array with both gel pads and gel wells (Figure 4.1d). The designs of different gel 
microstructures units are for the immobilization of different microparticles which will 
be discussed in detail in later sections.  
 
 
Figure 4.1 The mask design of the gel microstructure chip for microfluidic integration. 
(a) Microstructure array units. (b) Gel pad array unit. (c) Gel well array unit. (d) Mixed 
structure array unit. 
 
 
4.2.2.2 Fabrication process 
Polyacrylamide gel-based microstructures were fabricated in the similar way as the 
fabrication process for gel pad array units as described in Chapter 3. Polyacrylamide 
gel precursor solution was photopolymerized by exposure under UV through the hard 
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mask and the result microstructures were able to be attached to the TPM treated glass 
slide. The height of hydrated gel microstructures was defined by a pair of spacers. 12 
µm spacers were used for the fabrication of gel pad array unit while 24 µm spacers 
were used for the fabrication of gel well array unit as well as the mixed microstructure 
array unit. All the chips with gel microstructure arrays were stored in clean petri-dishes 
sealed with parafilm. The fabricated gel microstructure chip is shown in Figure 4.2. 
 
 
Figure 4.2 Gel microstructure chips. (a) Overview of gel microstructures chip. (b) Gel 
pad array. (c) Gel well array. (d) Mixed gel microstructure array. The scale bars 
represent 50 µm for (b), 100 µm for (c) and (d). 
 
 
4.2.3 Fabrication of PDMS-based microchannels 
The design of the microchannel features was done using AutoCAD software. The 
feature was then printed on a transparency soft mask. The master for soft-lithography 
was fabricated with standard photolithography process on 4 inch silicon wafers with 
detailed protocol described in Table 4.1.  
The PDMS microchannels were fabricated using a standard soft-lithography method 
[227]. First, the master was treated with trichloro(1H,1H,2H,2H-perfluorooctyl) silane 
to prevent the adhesion with PDMS prepolymer. A 10:1 (w/w) of PDMS base and 
PDMS curing agent was mixed and degassed for 40 min to remove air bubbles. Next, 
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the PDMS prepolymer mixture was poured onto the master and cured at 65 °C for 2 h. 
The replica PDMS microchannels were then peeled off from the master, punched with 
holes and diced as demanded. Two types of microchannels were fabricated with the 
channel width of 500 µm and 800 µm respectively. The entire PDMS microchannel 
fabrication process is summarized in Scheme 4.1.  
 
Table 4.1 Photolithography protocol for the fabrication of master for microchannel 
Steps Procedures 
Spin coat   
 500 rpm for 10 s 
 2000 rpm for 45 s 
Soft Bake  
 65 ºC for 7 min 
 95 ºC for 21 min 
 cooling down in air for 2 min 
Exposure   
 
365 nm UV light source, ~20 mW/cm2, exposure time 30 
s 
  
Post Exposure Bake (PEB)  
 65 ºC for 1 min 
 95 ºC for 6 min 
 cooling down in air for 2 min 
Develop  
 SU8 developer 10 min  
  
Rinsing  
 isopropanol + distilled water 
  
Hard Bake  
  150 ºC for 30 min 
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Scheme 4.1 PDMS microchannel fabrication process. 
 
4.2.4 Preparation of biofunctionalized microparticles 
4.2.4.1 Preparation of antibody-coated microbeads 
The method for the preparation of anti-hCG and anti-PSA microbeads are the same 
with the method mentioned in Chapter 3. Thus, it is omitted here. 
 
4.2.4.2 Preparation of enzyme-containing microparticles 
Enzyme-containing microparticles were prepared in a photopolymerization process 
with PEG-DA as shown in Scheme 4.2. Poly (ethylene glycol) diacrylate (PEG-DA, 
Mw 575 Da) was pre-dissolved with 2% (w/v) 2,2-dimethoxy-2-phenyl acetophenone 
(DMAP). The PEG-DA solution was then mixed with an equal volume of PBS 
solution which contained 5 mg/ml GOx and 5 mg/ml HRP. The mixed solution was 
transferred between a glass photomask and a glass slide and was then illuminated 
under a spot UV lamp (100 W, UVP) for 5 s. The photopolymerized cylindrical 
microparticles were around 50 µm in diameter as defined by the features on the mask 
and a pair of spacers. The height of the microparticles was defined by a pair of 12 µm 
spacers. Both the glass photomask and the glass slide were pre-treated with Repel 
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Silane to prevent the attachment of PEG-DA. After exposure, the polymerized PEG 
microparticles were rinsed out, washed with PBS for five times and stored at 4 °C. The 
current design of the mask allows simultaneous fabrication of 10000 enzyme-
containing microparticles.  
 
 
Scheme 4.2 Preparation of enzyme-containing PEG-based microparticles. 
 
4.2.5 Microfluidic biochemical assay  
4.2.5.1 Microfluidic setup 
The setup for the microfluidic microbead-based biochemical assay is shown in Figure 
4.3. The gel microstructure chip covered with certain microfluidic channel was placed 
onto a microscope mount. FEP tubings were used for the connection and reagent 
delivery. All the reagents were delivered into the microchannel by a syringe pump 
(Fusion 200, Chemyx Inc.) and an Eppendorf tube was used for waste collection. A 
20X magnification lens was used for imaging.  
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Figure 4.3 Experimental setup for microfluidic biochemical assays. Left: (1) Mercury 
Arc Power. (2) Syringe Pump. (3) CCD camera. (4) Microscope. (5) The gel 
microstructure chip. (6) Waste tube. Right: A close view of gel microstructure chip on 
the microscope mount. 
 
 
Figure 4.4 Microparticle arrays in microchannels. (a) Alignment of a gel pad array 
within a microchannel with antibody-coated microbeads deposited. (b) Alignment of a 
gel well array within a microchannel with enzyme-containing microparticles deposited. 
Scale bars represent 50 µm for (a) and 100 µm for (b). 
 
 
4.2.5.2 Microfluidic immunoassay 
The gel pad arrays were used to carry out microbead-based immunoassays. For the 
single-plexed assay for PSA and hCG, each gel pad array unit was first pipetted with 
0.1 µl solution of antibody-coated microbeads (~500 beads/µl). The microbeads 
solution was left to dry at room temperature for 2 min. The gel pad array unit was then 
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capped reversibly with a 500 µm wide PDMS microchannel (Figure 4.4a) which was 
connected with a syringe pump afterwards. PBS-B-T solution was first introduced at 2 
µl/min for 5 min to block the microchannel. FBS spiked with target analytes was then 
introduced into the microchannel at 2 µl/min for 10 min to allow the analytes to bind to 
the antibody on the microbeads’ surface. After PBS-B-T solution was pumped in at 5 
µl/min for 5 min to wash away any unbound analytes, 20 µg/ml of Alexa Fluor 594 
labelled detection antibody solution was introduced at 2 µl/min for 10 min. Finally, the 
microchannel was washed again with PBS-B-T at 5 µl/ min for 5 min to wash away 
any unbound fluorescent detection antibody. The gel pad array area was then imaged 
with a fluorescence microscopy.  
 
For the multiplexed immunoassay, the microbeads were diluted to ~100 beads/µl to 
allow more batches of microbeads to be deposited. After depositing one batch of 
microbeads onto the gel pads array, a bright field image was taken to record the spatial 
positions of every single microbead. The deposition and image recording process was 
repeated to encode different types of microbeads with their spatial addresses. The 
following microfluidic immunoassay procedure was similar to that of the single-plexed 
immunoassay despite that both analytes were spiked in FBS and a solution containing 
detection antibodies for both hCG and PSA was used. 
 
4.2.5.3 Microfluidic enzymatic glucose assay 
The gel well arrays were used for microparticle-based enzymatic assays for glucose. 
Each of the gel well array units was pipetted with 0.1 µl solution of enzyme-containing 
microparticles (~200 beads/µl). After the solution evaporated out in 2 to 3 min, the 
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array was rinsed from the side with PBS for 30 s to remove any microparticles which 
did not sit in the wells. The array was then capped reversibly with an 800 µm wide 
microchannel (Figure 4.4b). The microchannel was placed under a microscope and 
connected with a syringe pump. The microchannel was then washed with PBS at 5 
µl/min for 2 min. Next, PBS or FBS spiked with different concentration of glucose and 
20 µM of Ampliflu Red were introduced into the microchannel at 5 µl/min for 2 min. 
A fluorescence image was taken immediately afterwards.  
 
4.2.5.4 Simultaneous immunoassay and enzymatic glucose assay  
The mixed microstructure array was used for the simultaneous assay of proteins and 
glucose in serum. The enzyme-containing microparticles were first deposited onto the 
60 µm microwells through the same method mentioned above. The array was then 
pipetted with 0.1 µl solution of antibody-coated microbeads. After the solution was 
evaporated out, the array was gently rinsed from the side by PBS for 30 s. This step is 
to remove the 10 µm antibody-coated microbeads which could possibly sit on the 50 
µm cylindrical microparticles. A second batch of antibody-coated microbeads was then 
deposited in the same way. The microbeads coated with different antibodies were 
spatially encoded by comparing the images taken after deposition of each batch of 
microbeads. The mixed structure array was then capped with a microfluidic channel. 
After the microchannel was blocked with PBS-B-T, FBS spiked with 100 ng/ml of 
PSA, 1 µg/ml of hCG, 5 mM of glucose and 20 µM of Ampliflu Red was flowed 
through at 2 µl/min for 2 min. A fluorescence image was taken immediately to record 
the signals from the enzyme-containing microbeads. The FBS with analytes was then 
flowed through the channel for 10 min with the flow speed decreased to 2 µl/min. The 
following steps were the same for the multiplexing microfluidic immunoassay, which  
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Figure 4.5 Summary of the microfluidic microbead-based biochemical assay 
procedures.  (a) Single-plexed immunoassay. (b) Multiplexed immunoassay. (c) 
Enzymatic glucose assay. (d) Simultaneous immunoassay and enzymatic glucose assay. 
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including the first washing step, the introduction of Alexa Fluor labelled detection 
antibodies and the final washing step. A fluorescence image was taken afterwards to 
record the signal from the antibody-coated microbeads. 
 
The procedures for different microfluidic microparticle-based biochemical assay are 
demonstrated in Figure 4.5. 
 
4.2.6 Imaging and data analysis 
All bright field and fluorescence images were taken by a Retiga 4000R CCD camera 
(Qimaging) mounted on a BX41 Olympus fluorescence microscope (Olympus) 
equipped with a Texas Red filter (560 nm excitation, 595 nm dichroic mirror and 630 
nm emission, Chroma Technology). The exposure time for immunofluorescence was 
kept at 4s unless otherwise noted while the exposure time for the glucose assay was 2s 
but with the excitation light reduced by a 25% intensity grey filter (75% light blocked). 
The fluorescence intensity was measured by analyzing the pixel values of 
microparticles with Image J software (National Institutes of Health). The SEM images 
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4.3 Results and discussion 
4.3.1 Microparticle stability under microfluidic flow 
The good stability of microparticles under microfluidic flow conditions is the 
prerequisite for the microfluidic assays. Thus, the stability of microparticles on our 
gel-based microstructures was first tested. Protein-coated microbeads immobilized on 
four gel pad array units and enzyme-containing microparticles immobilized on eight 
gel well array units were subjected to a flow of 20 µl/min (1 cm/s flow velocity) of 
PBS for 30 min. As shown in Table 4.2, the particle count result shows nearly 100% 
stability of microparticles after the flow test. These results indicate that the 
microparticles on the gel-based microstructures should sustain the shear stress in the 
actual microfluidic bioassays which have much lower flow velocity compared to the 
test flow velocity. Moreover, the position of microparticles remained unchanged after 
the flow test (data not shown) which makes it possible to register and encode each 
batch of microbeads with fixed spatial addresses.  
  
Table 4.2 Numbers of micropaticles before and after microfluidic flow test 
Type of microparticles No. of microparticles 
Stability (%)  Before flow After flow 
streptavidin coated microbeads 191 191 100 
anti-hCG coated microbeads 316 316 100 
anti-PSA coated microbeads 339 338 99.7 
enzyme-containing microparticles 73 73 100 
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Figure 4.6 SEM images of (a) spherical streptavidin-coated polystyrene microbeads 
on a gel pad array and (b) cylindrical enzyme-containing PEG microparticles on a gel 
well array. 
 
While gel-based microstructure provided stable immobilization for both protein-coated 
polystyrene microbeads and PEG-based microparticles, the immobilization 
mechanisms could be different. As discussed in Chapter 3, the gel pad array holds 
polystyrene microbeads through not only physical entrapment but also the adhesive 
force between the gel and the microbeads as indicated by the dried gel pads which 
were deformed by the polystyrene microbeads (Figure 4.6a). The adhesive force could 
be ascribed to the sticky nature of polyacrylamide gel which was also used as a 
polymeric labelling adhesive [228]. Nevertheless, the adhesion between PEG-based 
microparticles and gel wells was not observed (Figure 4.6b). This indicated that PEG-
based microparticles were immobilized in gel wells merely through physical 
entrapment. The weak interaction between the PEG and polyacrylamide gel also 
allows the PEG-based microparticles which do not settle inside the microwells to be 
easily rinsed off by applying a flow from the side of the array. 
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4.3.2 Microfluidic microbead-based immunoassay for hCG and PSA 
PSA and hCG were chosen as the two target analytes in this study as both of them are 
important serum tumor markers as described in Chapter 3. In our study, all samples 
were prepared by spiking the analytes in FBS to mimic the conditions in real human 
serum. Calibration curves were generated with serial dilutions of hCG (0.0625, 0.125, 
0.25, 0.5, 1, 2, 4, 8, 16 ng/ml) and PSA (0.125, 0.25, 0.5, 1, 2, 4, 8, 16 ng/ml) (Figure 
4.7). Each error bar indicates one standard deviation of three individual experiments 
for samples with the same analyte concentration. In addition, immunoassays with 
blank FBS were performed. As shown in the calibration curves, for both hCG and PSA, 
the fluorescence intensity is proportional to the concentration of the analytes. The 
assay limit of detection (LOD) was determined to be 87 pg/ml (2.4 pM or 0.79 IU/l) 
for hCG and 114 pg/ml (3.4 pM) for PSA as calculated by adding three standard 
deviations to the measured mean value of the blank measurements while the assay. 
Limit of quantitation (LOQ) was determined to be 169 pg/ml (4.6 pM or 1.5 IU/l) for 
hCG and 253 pg/ml (7.4 pM) for PSA as calculated by adding six standard deviations 
to the measured mean value the blank measurements. As the commonly used cut-off 
serum concentration of hCG for testicular cancer diagnosis is 0.5 to 1 ng/ml (15 to 30 
pM [188]) and the cut-off concentration of PSA for prostate cancer diagnosis is 4 
ng/ml [194], both LODs in our immunoassay are lower than these cut-off 
concentration levels. Compared with other state-of-the-art microfluidic microbead-
based immunoassay [29, 33, 59], our immunoassay has similar or better detection limit 
while our microbead array are much easier to assemble and are made with materials of 
lower cost. As the immunoassay was done in less than 40 min using FBS sample, it 
can be potentially applied to the fast and sensitive analysis of hCG and PSA in real 
serum samples for cancer diagnostics.  
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Figure 4.7 Microfluidic microbead-based immunoassay calibration curve for (a) hCG 
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4.3.3 Multiplexed microfluidic immunoassay for hCG and PSA 
We further performed immunoassays for the simultaneous detection of multiple target 
tumor markers. Two types of antibody-coated microbeads were used for the detection 
of hCG and PSA while the bare streptavidin-coated microbeads were used as the 
negative control. These three types of microbeads were sequentially deposited onto the 
gel pad array with their spatial positions recorded after each deposition by imaging 
(Figure 4.8 aI-III). A microfluidic sandwich immunoassay for serum sample with 100 
ng/ml of PSA and 1 µg/ml of hCG was performed. No microbead loss or change of 
position was observed after the assay (Figure 4.8aIV). The anti-hCG and anti-PSA 
microbeads showed strong fluorescence and the streptavidin microbeads showed very 
weak fluorescence (Figure 4.8aV). Only one reporter dye, Alexa Fluor 594, was used 
in this experiment, which allowed the detection of multiple analytes with a basic 
fluorescence microscope equipped with a single fluorescence filter set. This eliminates 
the need for complicated read-out systems such as flow cytometers or microbarcode 
readers. The performance of the microbead-based multiplexed immunoassays was also 
examined by using serum samples spiked with different combinations of two tumor 
markers in their cut-off concentrations. As shown in Figure 4.8b, in the presence of 
hCG or PSA, only anti-hCG or anti-PSA microbeads showed strong fluorescence, 
while in the presence of both hCG and PSA, both anti-hCG and anti-PSA microbeads 
showed strong fluorescence. With no analyte in the sample, both anti-hCG and anti-
PSA microbeads showed very weak fluorescence. In all the experiments, the 
streptavidin-coated microbeads which were used as the negative control showed weak 
fluorescence signals. These results indicated the high-specificity of the antibodies used 
in this study which eliminated the cross reaction between antibodies and non-specific 
analytes.   
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Figure 4.8 Multiplexed microfluidic immunoassay for hCG and PSA. (a) Multiplexed 
immunoassay using spatially encoded microbeads. (I) to (III) the deposition of three 
batches of microbeads: streptavidin (I), anti-PSA antibody (II) and anti-hCG antibody 
coated microbeads (III). The latter two batches of microbeads are arrowed out. (IV) 
Bright field image after the immunoassay. (V) Fluorescence image after the 
immunoassay. Anti-hCG microbeads are arrowed. The scale bars represent 50 µm. (b) 
Multiplexed immunoassay for samples with different combinations of analytes. 
 
     
Although only three batches of microbeads were shown here, by controlling the 
density of microbeads in solution, more batches of microbeads can be sequentially 
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arrayed. In Chapter 3, we demonstrated the deposition and spatial encoding of 10 
batches of streptavidin-coated microbeads with no microbeads loss or change of 
position. To test whether the deposition process could influence the biofunctionality of 
antibody on the microbeads, a microfluidic immunoassay was performed on a gel pad 
array unit with 10 batches of anti-hCG microbeads pre-immobilized. Serum sample 
spiked with high concentration of hCG (2 µg/ml) was used to saturate all antibody-
binding sites on the microbeads resulting in the maximum signals. As shown in Figure 
4.9, the signal intensity of batch 1 microbeads was found to be ~85% compared to the 
signal intensity of batch 10 microbeads which was normalized to 100%. The reduction 
in signal intensity could result from a loose of antibody biofunctionality e.g. by the 
drying process during depositions. However, a sufficient high percentage of antibody 
remains intact to perform successful immunoassays. Thus, with the potential 
integration of antibody pairs for other tumor markers, our microfluidic microbeads-
based immunoassay platform could be promising for the diagnosis of different cancers 
from a single assay. 
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Figure 4.9 Biofunctionality of antibody-coated microbead batches. 10 batches of anti-
hCG microbeads were deposited sequentially and fluorescence signals after 
performing an hCG assay were recorded. Error bars represent the 1X S.D. of the 
fluorescence intensity of every batch of microbeads. The average fluorescence 
intensity of batch 10 microbeads is normalized to 1. 
 
 
4.3.4 Microfluidic microparticle-based enzymatic assay for glucose 
PEG based cylindrical microparticles which contain GOx and HRP were used for 
enzymatic glucose assays. The crosslinked PEG-DA has the appropriate pore size to 
entrap the big enzyme molecules while allowing small molecules, such as glucose, 
hydrogen peroxide and Ampliflu Red, to diffuse through [119, 120]. The fabricated 
microparticles, as shown in Figure 4.10, had a good monodispersity with average 
lateral diameter of 51.8 ±1.7 µm in the PBS buffer. The distribution of the 
microparticle sizes is shown in Figure 4.10b. 
The detection of glucose with the microparticles was through a coupled bi-enzymatic 
reaction previously reported [229]. The principle of the assay is shown in Figure 4.11. 
Once the sample flows through the microparticles, the GOx turns the glucose into 
gluconolactone and H2O2. With the catalysis of HRP, H2O2 reacts with the non-
fluorescent Ampliflu Red to generate strongly fluorescent resorufin. The resorufin can 
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Figure 4.10 Enzyme-containing microparticles. (a) Bright field image of enzyme-




Figure 4.11 Microparticle-based enzymatic glucose assay principle. 
 
then diffuse out of the PEG gel based microparticles. With the continuous feed of the 
glucose sample in microchannel, equilibrium is reached between the generation of 
resorufin inside the microparticle and the diffusion of resorufin out of the microparticle. 
The equilibrium results in a constant fluorescence intensity of the gel microparticles. 
In principle, this fluorescence intensity should be proportional to the concentration of 
glucose in the sample. 
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To develop quantitative microfluidic glucose assay, we first examined the time-
dependent fluorescence intensity of microparticles using 5 mM glucose sample in 
either PBS or FBS. The sample was introduced into the channel at 2 µl/min for 5 min 
and fluorescence images were taken every 10 s. With both PBS and FBS samples, the 
fluorescence intensity of microparticles gradually increased until it reached a steady 
state value after 2 min (Figure 4.12a). Therefore, for the quantitative detection of 
glucose, all the fluorescence images were taken right after 2 min flow through of 
sample. Microparticle-based enzymatic glucose assay were then performed to analyze 
a serial dilution of PBS and FBS samples spiked with 1.25, 2.5, 5 and 10 mM of 
glucose which covers the physiological glucose range (3 to 6 mM). The calibration 
curve for glucose is shown in Figure 4.12b. Each error bar indicates one standard 
deviation of three individual experiments for samples with the same concentration. We 
found a proportional relationship between the microparticle fluorescence intensity and 
the glucose concentration. Interestingly, the fluorescence signals arisen from the FBS 
samples were significantly lower than the signals arisen from the PBS samples. This 
could be attributed to the antioxidant species (uric acid and ascorbic acid etc.) in the 
FBS which consume the H2O2 generated by the first enzymatic reaction and thus 
reducing the amount of resorufin generated in the second enzymatic reaction. 
Compared with previous reported works which employed packed enzyme-containing 
microparticles for microfluidic assay of glucose spiked in buffer [49, 219], we used 
spatially separated microparticles which minimized the crossed contamination of 
resorufin diffused from one particle into another. As the cut-off concentration of 
fasting plasma glucose is 7.0 mM [230], our microparticle array could be potentially 
used for the diagnosis of diabetes mellitus using real human plasma sample. 
 
Chapter 4 - Microfluidic microparticle array on gel microstructure chip for 




Figure 4.12 Microfluidic microparticle-based enzymatic glucose assay. (a) Time 
dependent fluorescence of enzyme containing microparticles in the presence of 5 mM 
of glucose in either PBS or FBS. (b) Calibration curve for glucose in either PBS or 
FBS. 
 
Similar to the reuse of gel pad array as discussed in Chapter 3, the gel well array can 
also be reused by removing PEG-based microparticles. As shown in Figure 4.13, PEG 
microparticles can be removed from the gel wells array after 15 min sonication in pure 
ethanol. The re-deposited new batch of PEG microparticle (Figure 4.13c) can sustain 
the microfluidic flow after the 30 min flow test (Figure 4.13d) with no loss of 
microparticles. Furthermore, if desired, the PDMS microchannel can also be reused 
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after sonication in PBS-T (1X PBS, 0.05% w/v Tween 20) for 30 min and subsequent 
sonication in 100% ethanol for 30 min. 
 
Figure 4.13 Reuse of gel well array unit. (a) Deposited with microparticles; (b) 
Subsequent sonication in 100% ethanol for 15 min to remove microparticles; (c) 
Deposited with a new batch of microparticles; (d) Subjected to fluid flows (PBS at 20 
µl/min for 30 min). The microparticles are circled out. Gel-based microstructures with 
small defects (red arrowed) were intentionally used to demonstrate that the same arrays 
were employed. Scale bars represent 50 µm. 
 
4.3.5 Simultaneous detection of proteins and glucose in serum 
The mixed gel structure array which contains both 60 µm microwells and 20 µm 
micropads was used for the sequential immobilization of enzyme-containing 
cylindrical microparticles and antibody-coated spherical microbeads. The enzyme-
containing microparticles were deposited first (Figure 4.14a) as the smaller spherical 
microbeads can also sit in the microwells thus impeding the settlement of bigger 
cylindrical microparticles. The antibody-coated microbeads were then deposited and 
encoded by their spatial positions with bright field microscopic images (Figure 4.14b 
and c). A microfluidic bioassay was then performed to analyze a FBS sample spiked 
with 5 mM glucose, 100 ng/ml of PSA and 1 µg/ml of hCG. After the sample was 
flowed through for 2 min, the enzyme-containing microparticles showed strong 
fluorescence while all antibody-coated microbeads remained non-fluorescent (Figure 
4.14d). This result indicated that there was no non-specific absorption of the resorufin,  
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Figure 4.14 Simultaneous immunoassay and enzymatic assay for the detection of 
proteins and glucose. (a) Deposition of enzyme-containing microparticles. (b) 
Deposition of anti-PSA antibody-coated microbeads. (C) Deposition of anti-hCG 
antibody-coated microbeads which are arrowed out. (D) Fluorescence image taken 
with a 25% excitation light intensity filter after the enzymatic glucose assay. (E) 
Fluorescence image taken with a 25% excitation light intensity filter after the 
immunoassay. (F) Fluorescence image taken with no excitation light filtered after the 
immunoassay. Anti-hCG microbeads were arrowed out. The scale bars represent 50 
µm in all the figures. 
 
which diffused out of the enzyme-containing microparticles, onto the antibody-coated 
microbeads. After completion of the immunoassay, while the antibody-coated 
microbead became fluorescent, the fluorescence from the enzyme-containing 
microparticles was reduced as the majority of resorufin was washed away during the 
washing steps for the immunoassay (Figure 4.14e). A clearer image of the 
fluorescence from the antibody-coated microbeads is shown in Figure 4.14f which 
was taken through higher intensity of excitation light. Thus, the signals from the 
enzymatic assay and the signals from the immunoassay can be analyzed using the two 
images taken after 2 min of sample introduction (Figure 4.14d) and taken after the 
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completed immunoassay (Figure 4.14f). Notably, the fluorescence from the enzymatic 
assay (resorufin) and from the immunoassay (Alexa Fluor 594) was also detected by 
the same Texas Red filter set. Compared to the recently reported work for 
simultaneous immuno- and enzymatic assays using hydrogel-patterned nanofiber [231], 
our microfluidic assay based on microparticle array chip requires shorter assay time, 
has additional capability for simultaneous analysis of multiple antigens and is reusable. 
Thus, our microfluidic microparticle array platform could be potentially used for the 
fast and low-cost diagnosis of diabetes as well as testicular cancer and prostate cancer 
in a single bioassay. As immunoassay and enzymatic glucose assay represent two 
important types of biochemical assays, binding kinetic based assay and reaction kinetic 
based assay, the application of our microparticle array could be extended for the 
multiplexed detection of other categories of biomolecules, for example, DNAs 
(through binding kinetic based hybridization assay) [232] and other small metabolites, 
such as alcohol [39], choline [229] and uric acid (through reaction kinetic based 
enzymatic assays).  
 
4.4 Conclusion 
In this chapter, we integrated the gel based microstructure chip into a microfluidic 
platform for the microparticle-based bioassays. The integrated microfluidic platform 
was utilized for the quantitative fluorescence sandwich immunoassay for hCG and 
PSA in serum samples with LODs determined to be 87 pg/ml and 117 pg/ml 
respectively, which are one order lower than the cut-off concentration for cancer 
diagnosis. Enzymatic glucose assays were also performed using enzyme-containing 
PEG microparticles which were immobilized on novel gel well array. The glucose 
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assay had a dynamic response range from 0 – 10 mM which covers not only the 
physiological serum glucose level but also the threshold concentration for the 
diagnosis of diabetes mellitus.  
The multiplexing capability of our microfluidic microparticle array platform was first 
validated by the multiplexed immunoassay for hCG and PSA using spatially encoded 
microbeads. We also demonstrated simultaneous detection of hCG, PSA and glucose 
using microparticles immobilized on novel mixed microstructure array. A single 
wavelength fluorescent readout (Texas Red) with a common microscope was used to 
distinguish spatially encoded microparticles thus eliminating the need for complicated 
read-out systems. To the best of our knowledge, this is the first microfluidic 
microparticle array platform which enables the simultaneous immunoassay and 
enzymatic assay for the detection of different categories of biomolecules. This low 
cost, versatile and reusable microfluidic microparticle array platform could be 
promising for the rapid clinical diagnosis of multiple diseases which are related to 
either protein markers and/or metabolites through the analysis of real serum samples or 
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5.1 Introduction 
Point-of-care biomedical tests play an important role in the clinical diagnostics as they 
provide reliable results with less time, less sample volume, less assay steps, more 
simplified equipment and much lower cost as compared to the conventional 
biomedical assays performed in a specialized lab [233]. One example is the lateral 
flow test strip which integrates immunosensing elements into a simple membrane sheet 
and allows the qualitative or semi-quantitative detection of proteins in tens of 
microliters of blood or urine in 10 - 20 min without the requirement of any 
complicated equipment [162].  Microfluidic biochemical assay, with its fast reaction 
kinetics as well as the minute sample volume required, is a promising candidate to be 
applied to point-of-care diagnostics, especially for sensitive and quantitative 
determination of biomolecules in biofluids [234]. In conventional microfluidic 
biochemical assays, the samples and reagents are delivered by external pumping 
elements such as peristaltic pumps, syringe pumps and centrifugation devices. 
However, these external pumping elements usually consist of bulky operation units as 
well as external power source, thus making the microfluidic system not ideal for point-
of-care applications. It is thus demanded to develop passive pumping techniques which 
integrate pumping element inside a microfluidic system to substitute external pumps 
for point-of-care microfluidic assays. 




As reviewed in Chapter 2, a most frequently used passive pumping method is the 
capillary pressure (surface tension) driven pumping which employs wettable 
microstructures inside microfluidic networks to draw the fluid and to form a 
“microfluidic capillary system” for the application in external pump free microfluidic 
biochemical assays [36].  In such a microfluidic capillary system, the flow rate of the 
samples and reagents can be “programmed” by alternating the geometry of the 
microstructures [147] and the surface wettability (capillary pressure) of these 
microstructures [235]. The major biomedical application so far for microfluidic 
capillary systems is in the fast and sensitive quantitative immunoassays which are not 
applicable for lateral flow test strips [148]. Juncker et al. [36] pioneered the utilization 
of silicon based capillary systems for on-chip immunoassays. Reagents were delivered 
to the detection zone by simple sequential pipetting to the inlet and the tedious 
washing steps involved in conventional ELISA was totally avoided. Meanwhile, with 
this capillary system, detection limit for target protein in the picomolar concentration 
level was achieved [163] which is comparable to the ELISA method. Hereafter, an 
one-step immunoassay was developed on this capillary system as the user only needs 
to fill the inlet with one droplet of blood and wait for the final result to come out [149]. 
Moreover, a multiplexed immunoassay was also integrated into the capillary system as 
recently reported  by Wang et al. [161] with a glass-polymer hybrid chip.  
For most immunoassays performed in capillary systems, the antibody which serves to 
capture the target protein from the sample is patterned on a planar substrate such as a 
PDMS surface [150] or a glass surface [155]. As discussed in Chapter 3, three 
dimensional surfaces on microbeads enable more antibody molecules to be 
immobilized per unit of area and faster reaction kinetics as compared to planar 
substrate surface. However, in contrast to antibodies immobilized on planar surfaces, 




the integration of antibody conjugated microbeads into a capillary system was rarely 
reported.  Kim et al. [159] reported the introduction of packed microbeads in a 
polymer based capillary system for immunoassays. Total fluorescence signals from 
packed microbeads were correlated to the goat IgG concentration for quantitative 
analysis. However, this capillary system is less likely to be compatible with 
multiplexing protein analysis as encoding different microbeads from a packed cluster 
is very challenging. So far, there is still no report for multiplexed microbead-based 
immunoassay in a capillary system. 
In this chapter, a microfluidic chip is developed which, for the first time, integrates a 
microbead array into a capillary system for multiplexed immunoassays. The chip is 
based on a novel PEG-based capillary system for liquid delivery and a polyacrylamide 
gel pad array for microbead array assembly. Photopolymerization reactions are utilized 
for the fabrication of both capillary system and gel pad array with no cleanroom work 
involved during the fabrication. The filling time and flow rate of different fluids in the 
PEG-based capillary system can be altered by simple modification with different 
concentration of surfactant solution. On-chip sandwich immunoassays for PSA and 
hCG in serum samples are performed to validate the performance of the chip. Finally, 
the multiplexed immunoassays for PSA and hCG are demonstrated on the chip to 
verify its capability for multiplexed protein analysis. This microfluidic chip could be 
promising for the detection of multiple protein markers in real human serum sample 
for point-of-care diagnostics. 
 
 




5.2 Materials and Methods 
5.2.1 Materials and reagents 
Microscopic glass slides were purchased from Corning. Polydimethylsiloxane (PDMS) 
prepolymer (Sylgard 184) was purchased from Dow Corning. Sodalime hard masks 
were purchased from Infinite Graphic (Singapore). Streptavidin-coated polystyrene 
microbeads (~10 µm in diameter) were purchased from Bangs Laboratory. Repel silane 
(Dimethyldichlorosilane, 2% solution in octamethylcyclotetrasiloxane) was purchased 
from GE healthcare. Acrylamide/Bis-acrylamide solution (40%, 19:1), Poly(ethylene 
glycol) diacrylate (PEG-DA, Mw 575 Da), bovine serum albumin (BSA), N,N,N’,N’-
Tetramethylethylenediamine (TEMED), 3-(Trichlorosilyl)propyl methacrylate (TPM), 
Tween® 20, (+)-Biotin N-hydroxysuccinimide ester (biotin-NHS), DMPA, heptane and 
recombinant hCG were purchased from Sigma-Aldrich. Ethanol was purchased from 
Fisher Chemicals. PBS was purchased from 1st Base. Alexa Fluor 594 NHS ester and 
fetal bovine serum (FBS) were purchased from Invitrogen. PSA, monoclonal anti-PSA 
clone 5 antibody, monoclonal anti-PSA clone 7 antibody, monoclonal anti-β-hCG 
clone 1 antibody and polyclonal goat anti-whole hCG antibody were purchased from 
Arista Biologicals. Deionized water was produced by Arium® 611 UV system 
(Sartorius AG). 
 
5.2.2 The fabrication of the chip with capillary system and gel pad array 
5.2.2.1 The chip design 
The chips with capillary system and gel pad array were fabricated on microscopic 
glass slides with the dimension of 75 mm (L) x 25 mm (W) x 1 mm (H). The design  





Figure 5.1 The mask design for chip. Red area is chrome coated and black area is kept 
clear. (a) The design for polyacrylamide gel pad array units. Left: design of four gel 
pad array units on chip; Right: a single gel pad array unit; (b) The design for PEG-
based capillary system. Left: design of four capillary systems on chip; Middle: a single 
capillary system; Right: design of the components of a capillary pump. 
 
of the masks was done in AutoCAD software (Autodesk). The design of the masks 
allowed the fabrication of four polyacrylamide gel pad array units (Figure 5.1a) to be 
integrated into four PEG-based micropillar-rings (Figure 5.1b). Feature for each gel 
pad array unit remained the same as the feature in Chapter 3 and 4, which contains 17 
x 17 square gel pads (20 µm x 20 µm) with 10 µm gap (Figure 5.1a).  The design of 
the capillary system contains one inlet for the integration of the gel pad array unit, two 
flow resistor areas and two capillary pump areas (Figure 5.1b). All these components 
consist of 200 µm diameter circles with 50 µm gap between each other (Figure 5.1b). 




The entire features on the mask design cover an area of approximately 50 mm x 23 
mm which fits well onto a microscopic glass. 
 
5.2.2.2 Fabrication process 
The fabrication process for the chip consists of three steps: 
(1) Surface modification of the glass slides.  
      The glass slides were sequentially cleaned with ethanol, detergent and deionized 
water. They were then treated with 30% H2O2 for 30 min. These glass slides were 
subsequently treated with 5 mM TPM solution (4:1 heptane and chloroform [120]). 
The silanized glass slides were cleaned with ethanol and deionized water before being 
stored in a clean microscopic slide storage box.  
(2) Fabrication of polyacrylamide gel pad units through photopolymerization. 
The mask with features of gel pad array units was pre-treated with Repel Silane for 
15 min to prevent the attachment of polyacrylamide gel. Next, a 10% 
acrylamide/bisacrylamide precursor solution doped with 0.02% (w/v) DMPA and 1.2% 
(v/v) TEMED was transferred into the gap between the photomask and a TPM treated 
glass slides through capillary action. The height of the gap is defined by a pair of 12 
µm spacers. The solution was then UV exposed under a fluorescence microscope 
equipped with a mercury lamp, a 4X magnification lens and a DAPI filter (350 nm 
excitation). The power of the UV light was ~150 mW/cm2. Each gel pad array unit was 
exposed for 1 min which made the total fabrication time of 4 min. The glass slide with 
four patterned gel pad array units was then detached from the mask and washed with 
ethanol and deionized water.  
 




(3) Fabrication of PEG capillary system through photopolymerization. 
      The hard mask with features of capillary systems was spin coated with a thin layer 
of PDMS at the speed of 4000 rpm and was subsequently baked at 65 °C on a hotplate 
for 1 hour to cure the PDMS. This step is to prevent the adhesion between the PEG-
DA and the mask which ensures that polymerized PEG microstructures are not 
detached from the glass slide [236]. The PDMS modified hard mask was then 
manually aligned with the gel pad arrays on the glass slide to make sure each array unit 
was in the center of the inlet of the capillary system. A pair of 150 µm spacers was 
used to define the height of the gap between mask and the glass slide. The mask-
spacers-slide apparatus was then clamped from the side to prevent movement. 
Subsequently, pure PEG-DA pre-dissolved with 5% (w/v) DMPA was transferred into 
the gap. The apparatus was then put into the center of the chamber in a UV crosslinker 
(365 nm excitation; power of ~4 mW/cm2) and exposed with appropriate dose of UV.  
The chip with both gel pad array and PEG capillary system was then detached from the 
mask and washed with ethanol. Next, the chip was immersed into pure ethanol and 
stripped at 60 rpm on a rotator for 5 min to completely remove the unpolymerized 
PEG-DA residues and was then rinsed with deionized water to remove the ethanol. 
Finally, the chip was completely dried at 60 °C in an incubation oven for 10 min and 
then put in a clean petri dish and stored in a dry cabinet. The fabricated capillary 
system has approximately 15 µl of volume.  It is also noted that the assembly of the 
mask and the glass slides is done in a laminar flow cabinet to minimize the particle 
contamination and the PDMS coated mask can be cleaned with ethanol and reused for 
at least 50 times without the need for a new coating.  
The fabrication process is shown in Scheme 5.1 while the fabricated chip was shown 
in Figure 5.2. 





Scheme 5.1 Fabrication process of the chip. 
 
Figure 5.2 The capillary system chip integrated with gel pad arrays. Top: the chip with 
capillary system and four gel pad array units. Bottom from left to right: capillary pump 
region; flow resistor area; inlet; gel pad array unit. Scale bars represent 500 µm in 
images except the bottom rightmost image in which, the scale bar represent 50 µm. 
 




5.2.2.3 Surface modification of the capillary system 
The surface modification of the capillary system was done with a simple two-step 
procedure (Scheme 5.2). 20 µl of Tween® 20 solution was first pipetted onto the 
downstream 2nd capillary pump area on the chip. The chip was then immediately 
placed into a homemade wet chamber (100% humidity) to prevent evaporation. The 
solution autonomously filled the entire capillary system through capillary action. As 
polymerized PEG (contact angle of ~40°) has more hydrophilic surface than a TPM 
treated glass slide (contact angle of ~70°), the solution was trapped inside the PEG 
capillary system.  Subsequently, the chip was immediately dried in an oven at 60 °C 
for 10 min to evaporate out all the solution and let Tween® 20 to adsorb onto the 
surface of the capillary system. The modified chip was stored in the dry cabinet.  
 
 
Scheme 5.2 Method for surface modification of PEG capillary system. 
 




5.2.3 Flow test of the capillary system 
Flow tests were done on chips with the PEG capillary systems in a homemade wet 
chamber at RT (~22 °C). All the tests were done within 48 hrs after the surface 
modification of the capillary system. Three kinds of liquid, FBS, PBS-B-T solution 
(1X PBS, 1% BSA and 0.05% Tween® 20) and deionized water, were tested on the 
capillary system modified with different concentration of Tween® 20 solution (0.005, 
0.01, 0.02, 0.05% v/v). The liquid was pipetted onto the inlet in three consecutive steps 
with a volume of 5 µl for each pipetting step and a total volume of 15 µl. After each 
step, the fluid was allowed to autonomously flow into the capillary system, and the 
filling time was recorded from the pipetting of fluid to the stop of the fluid front. Right 
after the stop of the fluid front, the next pipetting was conducted. The total flow time 
was calculated by adding the filling time for three pipetting steps together.  
 
5.2.4 Preparation of antibody-coated microbeads 
The methods for the preparation of anti-hCG and anti-PSA microbeads are the same 
with the methods mentioned in Chapter 3. Thus, it is omitted here. 
 
5.2.5 On-chip immunoassay protocol 
For single-plexed immunoassays of hCG and PSA, 0.1 µl solution of antibody-coated 
microbeads (~500 beads/µl) was first pipetted onto a gel pad array unit. These 
microbeads settled down and were immobilized onto the gel pad array after the 
solution was evaporated out in ~2 min. The chip was then placed into a homemade wet 
chamber (100% relative humidity). The subsequent on-




three steps. First, 5 µl of FBS spiked with hCG or PSA was applied to the gel pad array 
and was allowed to autonomously fill the capillary system. Next, immediately after all 
the sample flow into the capillary system, 5 µl of FBS with 2 µg/ml of fluorescence 
detection antibody was pipetted onto the gel pad array. Finally, after the detection 
antibody was flowed through, 8 µl of PBS-B-T solution was applied to the inlet to 
wash out the unbound target analyte as well as the excess detection antibody. The total 
volume of liquid added is a little more than the volume of the capillary system to 
ensure that a layer of liquid was on the gel pad array which was to be imaged in 
hydrated conditions. A fluorescent image of the microbeads on the gel pad array was 
then taken with a microscope. 
For multiplexed immunoassays, two batches of microbeads, anti-hCG microbeads and 
anti-PSA microbeads, were sequentially deposited onto the gel pad array employing 
the same deposition procedure for single-plexed assay. After each deposition process, 
0.1 µl of PBS was added to the array region and an image was immediately taken to 
record the spatial address for every microbeads on hydrated gel pad array. The 
following immunoassay procedures were similar to the single-plexed immunoassay 
except that FBS samples were spiked with both analytes (PSA and hCG) and FBS with 
detection antibody for both analytes was used.  
 
5.2.6 Imaging and data analysis 
All bright field and fluorescence images were taken by a CCD camera (Retiga 4000R, 
Qimaging) mounted on a BX41 Olympus fluorescence microscope (Olympus) 
equipped with a Texas Red filter (560 nm excitation, 595 nm dichroic mirror and 630 




nm emission, Chroma Technology) and a mercury arc excitation source. The exposure 
time for immunofluorescence imaging was kept at 4 s unless otherwise noted. The 
fluorescence intensity was measured by analyzing the pixel values of microparticles 
with Image J software (National Institutes of Health). 
 
5.3 Results and discussion 
5.3.1 Optimization of fabrication of PEG microstructures 
Microstructures in a microfluidic capillary system can be fabricated with conventional 
microfabrication methods such as photolithography and etching [36], injection 
molding [152], hot embossing [153], soft-lithography [154, 155] and replica molding 
[159, 160].  Photolithography and etching method for silicon based substrate, which 
usually requires multi-step process in cleanroom with expensive equipment, is 
relatively tedious and uneconomical. Other methods, which are usually utilized to 
fabricated microstructures on polymer based substrate, are with less fabrication steps 
and with much lower material cost. Nevertheless, these methods all require certain 
micromolds with its fabrication still involving multi-step process in cleanrooms. 
In this study, we utilized the photopolymerization method to fabricated PEG 
micropillars on the glass slides. PEG-DA was chosen as the material not only because 
it is photo-curable but also due to the protein-repellent property of polymerized PEG 
which is suitable for immunoassay applications [184]. The fabrication method requires 
no pre-fabricated micromolds, no fabrication work in cleanroom and no expensive 
equipment. The fabrication time is ~20 min which includes all post-exposure steps. To 
optimize the fabrication process, the effect of UV exposure dose on the resulting PEG 




microstructures was first examined. As shown in Figure 5.3a, cone-like structures 
were formed with low dose of UV exposure (18 mJ/cm2). These cones are unstable as 
the dimension of the bottom is much smaller than the top, and therefore these 
microstructures collapsed upon the detachment of the glass slide from the hard mask. 
The formation of these cones indicates the undercure of deeper layer of the prepolymer 
which could be attributed to the absorption of UV light by the surface layer which 
reduced the penetration of incident light to the lower layer [237]. By increasing the 
exposure dose to 26 mJ/cm2, more UV light is allowed to penetrate the surface layer 
and thus cylindrical PEG micropillars can be formed as shown in Figure 5.3b. 
However, when exposure dose further increased to 34 mJ/cm2, the PEG micropillars 
crosslinked with each other in the bottom as shown in Figure 5.3c. As the exposure 
time was elongated, the crosslinked structures could arise from the increase of free 
radicals which diffuse out and react with the peripheral monomers or from the 
diffraction effect of the UV light. The effect of the exposure dose with the dimension 
of the PEG micropillars is demonstrated in Figure 5.3d. The diameter of the 
micropillars increases with the increase of the exposure time. Moreover, when the 
exposure dose rises to 30 mJ/cm2, the crosslinking between the micropillars emerges. 
These crosslinked micropillars are not desired as its effect on the flow behavior of 
liquid in the capillary system is unpredictable. Thus, for later fabrication of PEG 
micropillars for capillary system, exposure dose of 26 mJ/cm2 was employed to 
prevent the formation of either cone-like microstructures or crosslinked micropillars.  





Figure 5.3 Effect of exposure dose to the PEG-based microstructures. The 
microscopic picture of PEG-based microstructures with the exposure dose of (a) 18 
mJ/cm2; (b) 26 mJ/cm2; (c) 34 mJ/cm2. (d) Relationship of the exposure dose to the 
diameter of the PEG micropillars. Each diameter value is the average of diameters of 
30 micropillars. All scale bars represent 500 µm.  
 
The dimension of the microstructures determines the flow rate in a capillary system 
[147] and thus should be kept with reproducible consistence during the fabrication 
process. The consistence of the dimension of the PEG micropillars was examined with 




20 capillary systems fabricated on five chips. As shown in Figure 5.4, the average 
diameter of dried PEG micropillars with 26 mJ/cm2 is ~130 µm. The inter-chip CV of 
PEG micropillar diameter is 2.3% and intra-chip CV of PEG micropillar range from 
2.9% to 3.3%. These variances could result from the non-collimated UV light source 
and the energy fluctuation of the UV light in the UV crosslinker. The variance could 
be potentially reduced by using a collimated UV source for exposure, although, in this 
case, the equipment will cost much more than the current setup. 
 
Figure 5.4 Variance of the diameter of PEG micropillars. Exposure dose is 26 mJ/cm2. 
Each error bar indicates one standard deviation of the diameter of 120 micropillars on 
each chip (30 micropillars each capillary system).  
 
5.3.2 Flow test on PEG-based capillary system 
Flow test on PEG-based capillary system was done with three kinds of liquid: 
deionized water, PBS-B-T buffer and FBS. PBS-B-T buffer is the washing buffer, 
while FBS is the matrix for the sample and for the detection antibody in the 
immunoassay. The flow test was first conducted on unmodified PEG capillary systems. 
As shown in Figure 5.5a and 5.5b, although both PEG and TPM treated glass surfaces 
are hydrophilic, both deionized water and FBS cannot flow through the first resistance. 




In contrast, PBS-B-T can easily flow into the capillary system autonomously (Figure 
5.5c). This can be attributed to the higher wettability of PBS-B-T buffer as the 
surfactant Tween® 20 reduced the surface energy. In theory, in order to make capillary 
pump fillable with FBS and water, two strategies could be taken: (1) to dissolve FBS 
or water with surfactants to lower the surface tension of these liquids; (2) to modify the 
capillary system to increase the hydrophilicity of the surface. However, the accurate 
spiking of surfactant into certain volume of sample is only feasible in a professional 
lab and is not practical for point-of-care applications for users. Thus, rather than 
adding surfactant to the sample, we tried to make the surface of capillary system more 
hydrophilic by surface modification.  
 
Figure 5.5 Flow behavior of different liquid on the unmodified PEG capillary system. 
(a) Deionized water; (b) FBS; (c) PBS-B-T. All images were taken after the stop of the 
front of flow with pipetting of 5 µl of liquid. Scale bars represent 500 µm. 
.  
The surface modification of capillary systems was done by adsorbing Tween® 20 onto 
the surfaces of PEG micropillars and glass slides. Solutions with different 
concentrations of Tween® 20 (0.005, 0.01, 0.02, 0.05%, v/v) was utilized to 
autonomously fill the capillary system. As expected, the solution filling time decreases 
with increasing concentration of Tween® 20 (decreasing of surface tension) as shown 




in Table 5.1.  Tween® 20 was later adsorbed onto the capillary system after drying out 
the water.  
Table 5.1 Filling time of solution with different concentrations of Tween® 20 
  Concentration of Tween® 20 (v/v) 
  0.005% 0.01% 0.02% 0.05% 
Filling Time* (s) 646 ± 60** 277 ± 29 158 ± 26 49 ± 8 
                                                                                                                                                       
* Filling time is counted from the introduction of the solution onto the chip to the complete 
filling of the inlet.   
** One standard deviation of filling time from four capillary systems. 
 
Flow test on modified capillary systems was through three consecutive pipetting steps, 
with 5 µl of liquid applied onto the inlet in each step. The second and third 5 µl of 
liquid were pipetted onto the inlet immediately after the liquid pipetted in the previous 
step was entirely flow into the capillary system. As shown in Figure 5.6, the fronts of 
the liquid after each step are (1) passing the first flow resistor and into the first 
capillary pump; (2) pass the second flow resistor and into the second capillary pump; 
(3) filling the entire second capillary pump.  Each 5 µl represents one step in the 
immunoassay, with first 5 µl of sample introduction, second 5 µl of detection antibody 
introduction, and third 5 µl of washing. In contrast to the inability to flow into 
unmodified capillary system, both FBS and deionized water were able to 
autonomously flow into the Tween® 20 modified capillary systems. The change of the 
flow behaviour could be due to two reasons: (1) the increase of hydrophilicity 
(wettability) of the PEG micropillar and glass slide surface by Tween® 20; (2) the 
decrease of the surface tension of the liquid in the flow front by dissolving the Tween® 
20 on the capillary system surfaces. 





Figure 5.6 Fluid front after introduction of liquid. (a) after 5 µl; (b) after 10 µl; (c) 
after 15 µl. Fluid used was PBS-B-T with red food color.  
 
The filling time of different kinds of liquid in different filling steps is demonstrated in 
Table 5.2 and the total filling time is demonstrated in Table 5.3. As expected, PBS-B-
T, which has lower surface energy, took less time to fill the capillary system as 
compared to water and FBS, especially on the capillary system modified with lower 
concentration of Tween® 20. Moreover, filling time of the liquid becomes shorter on 
the capillary system modified with higher concentration of Tween® 20. This could be 
due to the more increased wettability of the capillary system surfaces with more 
Tween® 20 adsorbed and the more reduced surface tension of the liquid with more 
Tween® 20 dissolved. The average flow rate of liquid in different filling steps, as 
calculated from the filling time data in Table 5.2, is shown in Figure 5.7. The average 
flow rate increases on the capillary system modified with increased concentration of 
Tween® 20. This proves that the flow rate can be altered by simply modifying the 
capillary system with different concentration of Tween® 20 without changing the 
microstructure design. In other recently reported capillary systems, the flow rates of 
liquid were mainly altered by changing the design of either flow resistor or capillary 
pump [147, 150] or by patterning different region in the capillary system with different 
hydrophilicity [235]. Our approach could thus provide a new and effective method to 
alternate flow rate in a capillary system. 
 




Table 5.2 Filling time of each step introduction of liquid on Tween® 20 modified 
capillary system 
Liquid Type Filling time* (s)  
Concentration of Tween 20 
  0%** 0.005% 0.01% 0.02% 0.05% 
1st 5 µl 
PBS-B-T 79 ±4*** 68 ±5 45 ±8 29 ±1 23 ±2 
Water N/A**** 170 ±44 48 ±7 23 ±3 21 ±4 
FBS N/A 206 ±33 114 ±4 54 ±4 42 ±7 
2st 5 µl 
PBS-B-T 66 ±7 74 ±9 66 ±5 39 ±4 29 ±3 
Water N/A 128 ±7 110 ±17 65 ±7 43 ±5 
FBS N/A 189 ±29 150 ±11 57 ±6 39 ±10 
3rd 5 µl 
PBS-B-T 60 ±4 65 ±6 67 ±14 54 ±8 38 ±3 
Water N/A 70 ±3 70 ±12 63 ±5 48 ±6 
FBS N/A 130 ±25 147 ±19 92 ±5 74 ±7 
 
* Filling time is counted from the introduction of the solution onto the chip to the stop of the 
liquid front. 
** Unmodified capillary system. 
*** One standard deviation of filling time from three capillary systems on three different chips. 
**** Liquid cannot flow through. 
 
 
Table 5.3 Total filling time of liquid on Tween® 20 modified capillary system 
Liquid Type Total Filling time* (s)  
Concentration of Tween® 20 
  0%** 0.005% 0.01% 0.02% 0.05% 
PBS-B-T 206 ±8*** 207 ±1 178 ±15 123 ±9 91 ±5 
Water N/A**** 361 ±43 228 ±33 151 ±8 112 ±15 
FBS N/A 525 ±87 412 ±8 203 ±8 155 ±18 
                                                                                                                                           
* Total filling time is calculated by summing up the filling time of three steps liquid 
introduction. 
** Unmodified capillary system. 
*** One standard deviation of total filling time from three capillary systems on three different 
chips. 
**** Liquid cannot flow through.                                                                                                                               





Figure 5.7 Average flow rate of liquid of each filling step on capillary system 
modified with different concentration of Tween® 20. (1) Deionized water; (2) PBS-B-
T; (3) FBS. The average flow rate is calculated as (filling volume/average filling time). 
Each error bar represents one S.D. from three capillary systems on three different chips. 
 




Another interesting finding is that, water has less filling time (higher average flow rate) 
than the FBS in the capillary system. It is known that proteins in serum, such as 
albumins and immunoglobulins and fibrinogens, act as surfactants which result in the 
lower surface tension of serum than the pure water [238].  On the other hand, serum 
(human serum viscosity of 1.5 -1.9 centipoise [239]) has higher viscosity than pure 
water (~1.0 centipoise at 20 °C).  According to Equation 2.1 and 2.2 described in 
Chapter 2, in a capillary system, lower surface tension results in higher flow rate and 
shorter filling time while higher viscosity results in the lower flow rate and longer 
filling time. From our results, as FBS has longer filling time than water, it can be 
concluded that serum’s high viscosity has more dominated effect than its low surface 
tension on the flow rate and filling time in our capillary system.  
 
5.3.3 On-chip microbead-based immunoassay for PSA and hCG 
The detection for PSA and hCG was performed to validate the performance of on-chip 
microbead-based immunoassay. FBS was used as the sample to mimic the condition in 
real human serum. The immunoassay was done in three pipetting steps with the first 
step pipetting of FBS sample spiked with PSA or hCG, second step pipetting of 
detection antibody diluted in FBS and third step pipetting of PBS-B-T for washing. 
Capillary systems modified with 0.005% of Tween® 20, which enabled the longest 
filling time of liquid for the first and second pipetting of FBS (Table 5.2), were used 
for the immunoassay to provide enough incubation time for the binding between 
analytes with capture antibodies and between the detection antibodies with the analytes. 
The total immunoassay time is ~10 minutes. Serial dilutions of PSA (2 ng, 10 ng, 50 
ng, 250 ng/ml) and hCG (1 ng, 5 ng, 25 ng, 125 ng/ml) were tested on chip. Blank FBS  





Figure 5.8 Bright field (left) and fluorescence (middle) images of the inlet and the 
array during the immunoassay. (a) After sample introduction. (b) After detection 
antibody introduction. (c) After adding washing buffer. The enlarged fluorescence 
image of microbeads array after the assay for 250 ng/ml PSA is shown in the bottom. 
Scale bars represent 500 µm except for the bottom image in which the scale bar 
represents 100 µm. 
 
 





Figure 5.9 Calibration curves for on-chip immunoassay. (a) Calibration curve of PSA; 
(b) Calibration curve of hCG. Each error bar represents one standard deviation of 
fluorescence signals of all the microbeads on one gel pad array.  
 
was used as 0 ng/ml sample. The images of the inlet and the array during the three-step 
immunoassay process are shown in Figure 5.8. After introduction of FBS sample, 
there is very weak fluorescence in the inlet while no fluorescence is shown in the gel 
pad array region (Figure 5.8a). After the subsequent introduction of fluorescence 
detection antibody, there is strong fluorescence from the microbeads as well as from 
the other inlet region (Figure 5.8b). Notably, only the peripheral of the PEG 
micropillars shows strong fluorescence which indicates that the detection antibody  
cannot diffuse into the PEG matrix [119]. Finally, after the washing buffer is added, 
non-binding analytes and excess detection antibody are washed out, resulting in the 
low background noise around the inlet and the gel pad array (Figure 5.8c). The 
calibration curves for PSA and hCG are shown in Figure 5.9. The fluorescence signal 
is proportional to the concentration of analytes and the linear range is 0 – 50 ng/ml for 
PSA and 0 – 25 ng/ml for hCG. The calculated limits of detection (LODs) based on the 
3 S.D. rule are 0.31 ng/ml for PSA and 0.73 ng/ml for hCG. The LOD for PSA is 
lower than the commonly used serum cut-off value (4 ng/ml [194]) for prostate cancer 
screening and the serum cut-off value (2 ng/ml [188]) for the monitoring of prostate 
cancer recurrence after radiotherapy while the LOD for hCG is lower than the cut-off 




value (10 U/l or 1.0 ng/ml [188]) for testicular cancer screening. The LODs could be 
potentially improved by enabling longer incubation time which can be achieved by 
either increasing the area of capillary system to accommodate bigger sample volume or 
elongating the flow resistor region to reduce the average flow rate. Thus, our chip 
could be potentially used for rapid and sensitive point-of-care cancer diagnostics. Most 
of the previous immunoassays performed on capillary system employed antibodies 
which were patterned on planar surfaces with microfabricated microstamps or 
microchannels [149, 155, 161]. In this case, redundancy of the data points was enabled 
by patterning multi-lines of antibodies. In this work, the utilization of randomly 
arrayed microbeads not only allows more antibody to be immobilized per unit of area 
but also simplifies the process to introduce antibody into the capillary system while 
microbeads also enables the redundancy of data points. 
 
5.3.4 Multiplexed on-chip immunoassay  
Simultaneous detection of both PSA and hCG was also achievable on our chip using 
the spatial encoding method mentioned in Chapter 3 and Chapter 4. As shown in 
Figure 5.10a and 5.10b, anti-PSA microbeads and anti-hCG microbeads were 
sequentially deposited onto gel pad array and their spatial positions were recorded in 
images. After the assay, the fluorescence signals from both kinds of microbeads can be 
obtained with single fluorescence filter set on a single image (Figure 5.10c) and the 
fluorescence intensity can then be analyzed. FBS samples spiked with different 
concentration of two analytes (1, 5, 25, 125 ng/ml hCG with 2, 10, 50, 250 ng/ml PSA)  





Figure 5.10 On-chip multiplexed immunoassay using spatially encoded microbead 
array. (a) Deposition of anti-PSA microbeads; (b) Deposition of anti-hCG microbeads; 
(3) Fluorescence image after the immunoassay with FBS sample spiked with 50 ng/ml 
PSA and 20 ng/ml hCG. Scale bars represent 50 µm. (d) Microbead fluorescence 
signal as a function of analyte concentration in multiplexed immunoassay. Each error 
bar represents one standard deviation of fluorescence signals of one type of 
microbeads on one gel pad array.  
 
were tested on chip. As demonstrated in Figure 5.10d, fluorescence signals are 
proportional to the signal intensities and the function accords well with the calibration 
curve obtained in the single-plexed assay. With other available antibody pairs, the 
number of analytes which can be simultaneously analyzed could be increased simply 
by encoding more batches of microbeads as discussed in Chapter 3.  Previously, 
Wang et al. [161] developed immunoassay in a capillary system wherein the 




multiplexing capability was achieved by hybridization of oligonucleotide conjugated 
antibodies with site-specifically patterned complementary oligonucleotides. However, 
the antibody immobilization process is time-consuming as the patterning of 
oligonucleotide probes took more than 4 hrs and the subsequent hybridization step also 
required ~1 hr [164]. In this work, the antibody coated microbeads is simply pipetted 
onto the gel pad array and each deposition and encoding step takes ~3 minutes. Thus, 
our method could be a more flexible and more rapid one to achieve multiplexing 
capability for immunoassay in a capillary system. 
 
5.4 Conclusion 
In this work, we successfully employ PEG to be a new candidate material for the 
fabrication of microstructures in a capillary system. The fabrication process of PEG-
based capillary system is fast, simple and reproducible while no mold, no cleanroom 
facilities and expensive equipment is required during the process. The modification of 
the surface of the capillary system by different concentration of Tween® 20 enables the 
filling time and average flow rate to be changed without the need to change the 
microstructure design. A microfluidic chip, which integrates the gel pad array into the 
capillary system, is fabricated and the chip allows the microbead-based immunoassay 
to be performed within 10 min. The quantitative detection of two serum tumor markers, 
PSA and hCG, is done with the LODs below the cut-off value for cancer diagnosis. 
Moreover, with spatially encoded microbead array, quantitative and multiplexing 
protein detection is also achieved on chip. In the future, this chip will be optimized 
toward the one-step and multiplexed protein detection in blood samples to contribute 
to the low-cost, multi-targets and rapid serum/blood based point-of-care tests for 
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6.1 Conclusion 
In this PhD work, a novel microparticle array platform has been developed based on 
the assembly of microparticles on polyacrylamide gel microstructures. These gel 
microstructures have been fabricated on inexpensive microscopic glass slides with 
photopolymerization reaction through a mask. The fabrication protocol has been 
optimized to enable much lower autofluorescence from the gel as compared to the high 
autofluorescence from previous reported gel-based microstructures [5], thus making 
these new generation gel-based microstructures suitable for sensitive and quantitative 
microparticle-based biochemical assays rather than for only semi-quantitative DNA 
hybridization assays with the previous gel pad array platform [5,139]. The fabrication 
process is rapid (1 min/per microstructure unit) with very low material cost and, 
without the need for a cleanroom and expensive equipment. Besides the simplicity for 
fabrication, gel microstructures enable stable immobilization and effective assembly of 
microparticles with different surface bioprobes. In this work, three types of gel 
microstructure chips with different designs have been fabricated for various 
applications in multiplexed biochemical assays. 
The first type of gel microstructure chip (Chapter 3) consists of 40 gel pad array units 
with distances between each two gel pad array units fitting for the multi-channel 
micropipette for simple on-chip liquid handling. PEG micropillar rings have been 
introduced onto the chip to serve as hydrophilic barriers around each array unit to trap 
the liquids and thus 40 different microbead-based biochemical assays can be 
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simultaneously performed on chip. Quantitative fluorescence immunoassays for 
human chorionic gonadotropin (hCG) and prostate specific antigen (PSA) have been 
successfully done on chip with limits of detections at least one order lower than the 
cut-off concentrations of these two tumor markers for cancer diagnosis. Moreover, as 
most of microbeads (> 99%) remain in their initial position after the assay, multiplexed 
immunoassay for hCG and PSA is enabled by encoding batchwise deposited 
microbeads with their spatial addresses on the array. The spatial encoded microbead 
array eliminates the need for color encoding or barcode encoding as well as the 
corresponding complicated decoding process. In addition, the chip can be reused by 
simply dissolving polystyrene based microbeads with toluene and subsequent 
depositing of new microbeads. The reusability is further validated in immunoassays for 
hCG and there is no compromise of the stability of microbeads as well as the 
sensitivity of the immunoassay with the reused chip. Lastly, in a preliminary study, the 
on-chip simultaneous detection of DNA and protein has also been achieved with arrays 
of oligonucleotide and antibody coated microbeads. In sum, this low cost gel pad array 
chip allows sensitive and high throughput immunoassay to be performed with merely 1 
µl of serum sample for each multiplexed assay and thus could have good potential to 
be employed for clinical diagnostics. 
The second type of gel microstructure chips (Chapter 4) is designed to be integrated 
into a microfluidic system. Three different gel microstructures, gel pad array, gel well 
array and mixed microstructure array, have been fabricated for the assembly of 
antibody coated microbeads, enzyme containing microparticle and the both types of 
microparticles, respectively. With microbead arrays assembled on gel pad arrays, 
microfluidic quantitative immunoassays for hCG and PSA in serum have been 
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demonstrated with LODs lower than their cut-off concentration for cancer diagnosis. 
Multiplexed immunoassay for hCG and PSA has also been achieved with spatially 
encoded microbeads. Meanwhile, with microparticle array assembled on gel well array, 
microfluidic quantitative enzymatic glucose assays have also been demonstrated with 
the dynamic response range covers not only the physiological serum glucose level but 
also the threshold concentration for the diagnosis of diabetes mellitus. Furthermore, 
antibody coated microbeads and enzyme containing micropaticles have been 
assembled on the mixed microstructure array for the simultaneous immunoassays and 
enzymatic glucose assays. This is the first time the integration of a binding kinetic 
based assay (immunoassay) with a reaction kinetic based assay (enzymatic glucose) 
into one microparticle microarray platform. This versatile microfluidic microparticle 
array platform could be promising to be applied to the simultaneous detection of 
protein markers and metabolite for disease diagnostics.  
The third type of gel microstructure chip (Chapter 5) is designed to be integrated into 
a passing pumping system, PEG-based capillary system. The PEG-based capillary 
system consists of PEG micropillars fabricated by photopolymerization reaction with 
no mold and without the need for cleanroom facilities, which is much more simplified 
than any other existing capillary systems fabricated with either silicon/glass or 
polymeric materials. These PEG micropillars have been fabricated on glass slides with 
reproducible dimension by controlling the UV exposure dose. With the intrinsic 
protein repellent property of PEG, pre-blocking steps, which is required for all the 
other existing capillary systems for immunoassays, is eliminated and thus further 
adding to the simplicity of this system. The filling time and average flow rate of liquid 
on the capillary system can be simply altered by modification with different 
concentration of Tween® 20 surfactant. After the integration of the gel pad array into 
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with PEG capillary system, the chip is tested by microbead-based immunoassays for 
PSA and hCG. The on-chip quantitative immunoassays require only three filling steps 
and 10 min assay time and the LODs of two serum tumor markers are lower than the 
cut-off concentrations for cancer diagnosis. Moreover, on-chip multiplexing 
immunoassay has also been achieved simply by using spatially encoded microbead 
array. This is, to the best of our knowledge, the first bioanalytical microbead array to 
be integrated into an autonomous capillary system for multiplexing biochemical assays. 
The characteristics for these three types of gel microstructure chips are summarized in 
Table 6.1. 
In sum, this thesis work developed an easy-fabricated, easy-integrated, low cost, 
flexible and versatile platform for the assembly of microparticle arrays for various 
kinds of biochemical assays. This novel platform could be a useful and more 
accessible research tool for common biolabs to customize their own microparticle 
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Table 6.1 Comparison of three types of gel microstructure chips in this work 
  




Capillary system  
& gel pad array 
chip   
Sample Volume 1 µl 20 µl (immunoassay);      
4 µl (glucose assay)  
5 µl 
Assay Time < 1.5 hrs 
(immunoassay) 
40 min (immunoassay); 
5 min (glucose assay)      
< 10 min 
(immunoassay) 
Performance LODs:                        
42 pg/ml for 
hCG;  136 pg/ml 
for PSA 
LODs:                            
87 pg/ml for hCG;        
114 pg/ml for PSA                                          
Range for glucose:           
1 - 10 mM                                                       
LODs:                         
0.31 ng/ml for 
PSA;  
0.73 ng/ml for hCG 
Multiplexing Yes (also for 
protein and DNA) 





Spatial  Spatial + Size Spatial 
Microfluidics No Yes Yes 
Fabrication time  < 1 hr 10 min < 30 min 
   







Assays per chip 8 40 4 
 
   
Trained User Yes Yes No 
 
 
6.2 Future Works 
 In this PhD work, polyacrylamide gel has been used for the fabrication of 
microstructures. Polyacrylamide gel shows strong adhesion with antibody and 
oligonucleotide coated polystyrene microbeads. It is necessary to investigate 
the actual mechanism behind the adhesion and the stability of microbeads with 
other surface chemistry could also be tested on the gel microstructures. 
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Furthermore, gels with other polymeric materials may also be utilized and 
tested for the assembly of microparticle-based microarray. 
 
 The 2-plex immunoassay and 3-plex detection of proteins and glucose were 
demonstrated in this thesis with the current microparticle array platform. 
However, the multiplexing power of our platform, which is theoretically 
infinite, has not been fully explored. In practice, there are several potential 
challenges to apply our microparticle array to high-multiplexing bioanalysis. 
First, the likelihood of the cross-reactivity between the antibodies or other 
bioprobes will increase when more types of analyte exist in the same sample. 
This may cause false positive signals. Second, with increasing batches of 
microparticles deposited, new batches of microparticles will get less chance to 
settle on the gel microstructure array given the less available immobilization 
sites (cross-points for gel pad array, wells for gel well array.). This may cause 
decreasing number of microparticles to be immobilized in later batches and in 
the extreme case, there could be no microparticles in certain batch which is 
deposited. In this case, the adjustment of microparticle density in the solution 
should be important to ensure that enough number of microparticles can be 
immobilized for every later batch. Finally, the manual imaging of each array 
after each deposition step for spatial encoding could be tedious if large number 
of batches of microparticles is to be immobilized. Thus, to achieve high 
multiplexing capability, certain automation and integration is needed for the 
deposition process which includes the deposition, imaging and microparticle 
pattern recognition. All these challenges need to be conquered in the future 
work. 
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 Fetal bovine serum (FBS) has been used as the medium for samples throughout 
this work. As FBS shares similarity in constitution with real human serum, the 
use of the gel microstructure chip for the analysis of multiplexed protein 
markers in human serum sample could be achievable and promising for the 
clinical diagnostics. 
 
 The readout of the fluorescence signals from the microparticle array is 
currently through fluorescence microscopy and the analysis of the signals is a 
manual process. In the future work, the gel microstructure chip may be 
designed to be compatible with microscanners and with automated imaging 
analysis software to provide faster assay as well as faster data analysis. 
 
 
 The gel pad array chip (Chapter 3) enables the microparticle-based 
biochemical assays to be performed with only 1 µl of sample volume. Thus, the 
chip could have other bioanalysis applications wherein the collection of big 
amount of samples is difficult and challenging. These applications include the 
biomarker detection in fetal blood/serum, the bioanalysis of the cell lysate, the 
bioanalysis of extract from tissue biopsy and the hybridization assay for DNA 
samples amplified from on-chip µPCR or from 384 or 1536 wells microplate 
PCR. In addition, by reducing the distance between the two gel pad array units 
and by decreasing the size of the PEG micropillar ring, the current throughput 
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 The capability of the mixed microstructure chip (Chapter 4) to allow 
simultaneous immunoassay and enzymatic assay to be performed could be 
further used in real disease diagnostics. As mentioned in Chapter 1, the 
diagnostics of insulinoma requires the quantitation of serum glucose and 
insulin which usually requires two separated assays. With microbeads coated 
with anti-insulin antibody and with the enzyme containing microparticle for 
glucose, a one-assay diagnosis of insulinoma could be achieved which may 
greatly reduce the diagnosis time and may enable fast treatment.  
 
 The crosslinked PEG has been shown in Chapter 4 to trap big molecules while 
letting small molecules to diffuse freely. It may be interesting to further 
investigate the cut-off molecular weight for different concentrations of 
polymerized PEG under different conditions such as ionic strength and pH.  
These cut-off molecular weight values may be helpful for the design of novel 
microparticle-based biosensors. 
 
 In Chapter 5, flow test has been done on PEG-based capillary systems with 
one particular design. PEG-based capillary systems with other designs could 
also be fabricated and tested. For example, the length of the flow resistor, the 
dimension of the PEG micropillar or the area of the capillary pump can all be 
altered to give different filling times. With these alternations, the capillary 
system could be optimized to improve the performance of on-chip microbead-
based immunoassay. The capillary system may be further designed to fit for the 
one-step lateral flow multiplexed immunoassay based on the microbead array. 
A potential design for blood samples is shown in Figure 6.1. With this design, 
the challenge could lie in (1) the fabrication of much smaller PEG-based 
Chapter 6 - Conclusion & Future Works 
145 
 
microstructures at the inlet for blood filtering and in the region for microbead 
array assembly for microbead physical confinement; (2) the need for a robust 
reproducible method to pre-immobilize antibodies onto the chip; (3) the proper 
mixing between the sample and the detection antibody in the mixer. Thus, 
solutions should be found to overcome these challenges. 
 
 
Figure 6.1 A potential design for the PEG capillary system for one-step multiplexed 
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